Alleviating Neurodegenerative Diseases Associated with Mitochondrial Defects by Therapeutic Biomolecules

Neurodegenerative diseases are emerging as a global health concern in the current sce-nario, and their association with mitochondrial defects has been a potential area of research. Mi-tochondria, one of the essential organelles of the cell, serve as the cell's powerhouse, producing energy and ensuring cellular health. Neurodegenerative diseases such as Alzheimer's, Parkinson's, Huntington's, amyotrophic lateral sclerosis, and Pelizaeus-Merzbacher disease have been found to be primarily triggered by mitochondrial malfunction. One of the key byproducts of mitochondrial respiration, reactive oxygen species, also contributes significantly to mitochondrial DNA muta-tions that eventually cause mitochondrial breakdown. This review paper comprehensively examines the potential of therapeutic biomolecules, specifi-cally mitochondria-specific antioxidants, in mitigating the impact of mitochondrial defects on neurodegenerative diseases. It provides a detailed analysis of the mechanisms involved in mito-chondrial dysfunction, the potential therapeutic targets of these biomolecules, and their structure-activity relationship information are also discussed in this review. Various research articles and publications were used extensively in compiling the data, and the structures of biomolecules were prepared using software such as ChemDraw and ChemSketch. Crucial elements triggering mitochondrial abnormalities were identified and a tabular compilation of bioactive antioxidant compounds along with their therapeutic targets, was presented. Mitochondria-specific antioxidant therapy is an innovative and promising strategy for the man-agement of neurodegenerative diseases associated with mitochondrial defects. This review pro-vides a thorough summary of the current state of research and promising avenues of research and development in this field, emphasizing the importance of further investigations and clinical trials to elucidate their therapeutic benefits.

Clinical Progress of Targeted Therapy for Breast Cancer: A Comprehensive Review

The discovery of effective breast cancer therapy is both urgent and daunting, beset by a myriad of challenges that range from the disease's inherent heterogeneity to its complex molecular underpinnings. Drug resistance, the intricacies of the tumor microenvironment, and patient-specific variables further complicate this landscape. The stakes are even higher when dealing with subtypes like triple-negative breast cancer, which eludes targeted hormonal therapies due to its lack of estrogen, progesterone, and HER2 receptors. Strategies to overcome such challenges include combinations of drugs and identifying new drug targets. Developing new drugs based on such targets could be a better solution than relying on costly immunotherapy or combinational therapies. In this review, we have endeavored to comprehensively examine the proven therapeutic drug targets associated with breast cancer and elucidate their respective molecular mechanisms and current clinical status. This study aims to facilitate researchers in conducting a comparative analysis of different targets to select single and multi- targeted drug discovery approaches for breast cancer.

Synthesis, in silico screening, and biological evaluation of novel pyridine congeners as anti-epileptic agents targeting AMPA (α-amino-3-hydroxy-5-methylisoxazole) receptors

The research involves the synthesis of a series of new pyridine analogs 5(i-x) and their evaluation for anti-epileptic potential using in silico and in vivo models. Synthesis of the compounds was accomplished by using the Vilsmeier-Haack reaction principle. AutoDock 4.2 was used for their in silico screening against AMPA (-amino-3-hydroxy-5-methylisoxazole) receptor (PDB ID:3m3f). For in vivo testing, the maximal electroshock seizure (MES) model was used. The physicochemical, pharmacokinetic, drug-like, and drug-score features of all synthesized compounds were assessed using the online Swiss ADME and Protein Plus software. The in silico results showed that all the synthesized compounds 5(i-x) had 1-3 interactions and affinities ranging from -6.5 to -8.0 kJ/mol with the targeted receptor compared to the binding affinities of the standard drug phenytoin and the original ligand of the target (P99), which were -7.6 and -6.8 kJ/mol, respectively. In vivo study results showed that the compound 5-Carbamoyl-2-formyl-1-[2-(4-nitrophenyl)-2-oxo-ethyl]-pyridinium gave 60% protection against epileptic seizures compared to 59% protection afforded by regular phenytoin. All of them met Lipinski's rule of five and had drug-likeness and drug score values of 0.55 and 0.8, respectively, making them chemically and functionally like phenytoin. According to the findings of the studies, the synthesized derivatives have the potential to be employed as a stepping stone in the development of novel anti-epileptic drugs.

Recent Insight into Herbal Bioactives-Based Novel Approaches for Chronic Intestinal Inflammatory Disorders Therapy

Inflammatory bowel disease (IBD) is a life-threatening complex disease. It causes chronic intestinal inflammation in GIT. IBD significantly affects people's lifestyles and carries a high risk of colon cancer. IBD involves the rectum, ileum, and colon, with clinical manifestations of bloody stools, weight loss, diarrhea, and abdominal pain. The prevalence of inflammatory disease is increasing dramatically worldwide. Over 16 million people are affected annually in India, with an economic burden of $6.8- $8.8 billion for treatment. Modern medicine can manage IBD as immunosuppressive agents, corticosteroids, tumor necrosis factor antagonists, integrin blockers, and amino-salicylates. However, these approaches are allied with limitations such as limited efficacy, drug resistance, undesired side effects, and overall cost, which cannot be ignored. Hence, the herbal bioactives derived from various plant resources can be employed in managing IBD. Science Direct, PubMed, Google, and Scopus databases have been searched for conclusively relevant herbal plant-based anti-inflammatory agent compositions. Studies were screened through analysis of previously published review articles. Eminent herbal bioactives, namely curcumin, resveratrol, ellagic acid, silybin, catechin, kaempferol, icariin, glycyrrhizin acid, berberine, quercetin, rutin, and thymol are reported to be effective against IBD. Herbal leads are promising treatment options for IBD; they have been shown to display antiinflammatory and antioxidant properties by targeting enzymes and regulating the expressions of various inflammatory mediators. Natural products have been reported to have anti-inflammatory properties in various clinical and preclinical studies, and some are available as herbal preparations. Herbal medicine would be promising in association with the implication of a novel drug delivery system for managing IBD.

Novel Approaches for the Management of Type 2 Diabetes Mellitus: An Update

Diabetes mellitus is an irreversible, chronic metabolic disorder indicated by hyperglycemia. It is now considered a worldwide pandemic. T2DM, a spectrum of diseases initially caused by tissue insulin resistance and slowly developing to a state characterized by absolute loss of secretory action of the β cells of the pancreas, is thought to be caused by reduced insulin secretion, resistance to tissue activities of insulin, or a combination of both. Insulin secretagogues, biguanides, insulin sensitizers, alpha-glucosidase inhibitors, incretin mimetics, amylin antagonists, and sodium-glucose co-transporter-2 (SGLT2) inhibitors are the main medications used to treat T2DM. Several of these medication's traditional dosage forms have some disadvantages, including frequent dosing, a brief half-life, and limited absorption. Hence, attempts have been made to develop new drug delivery systems for oral antidiabetics to ameliorate the difficulties associated with conventional dosage forms. In comparison to traditional treatments, this review examines the utilization of various innovative therapies (such as microparticles, nanoparticles, liposomes, niosomes, phytosomes, and transdermal drug delivery systems) to improve the distribution of various oral hypoglycemic medications. In this review, we have also discussed some new promising candidates that have been approved recently by the US Food and Drug Administration for the treatment of T2DM, like semaglutide, tirzepatide, and ertugliflozin. They are used as a single therapy and also as combination therapy with drugs like metformin and sitagliptin.

In Search of Novel SGLT2 Inhibitors by High-throughput Virtual Screening

BACKGROUND

Type 2 diabetes mellitus constitutes approximately 90% of all reported forms of diabetes mellitus. Insulin resistance characterizes this manifestation of diabetes. The prevalence of this condition is commonly observed in patients aged 45 and above; however, there is an emerging pattern of younger cohorts receiving diagnoses primarily attributed to lifestyle-related variables, including obesity, sedentary behavior, and poor dietary choices. The enzyme SGLT2 exerts a negative regulatory effect on insulin signaling pathways, resulting in the development of insulin resistance and subsequent elevation of blood glucose levels. The maintenance of glucose homeostasis relies on the proper functioning of insulin signaling pathways, while disruptions in insulin signaling can contribute to the development of type 2 diabetes.

OBJECTIVE

Our study aimed to investigate the role of SGLT2. This enzyme interferes with insulin signaling pathways and identifies potential SGLT2 inhibitors as a treatment for managing type 2 diabetes.

METHODS

We screened the Maybridge HitDiscover database to identify potent hits followed by druglikeness, Synthetic Accessibility, PAINS alert, toxicity estimation, ADME assessment, and Consensus Molecular docking.

RESULTS

The screening process led to the identification of three molecules that demonstrated significant binding affinity, favorable drug-like properties, effective ADME, and minimal toxicity.

CONCLUSION

The identified molecules could manage T2DM effectively by inhibiting SGLT2, providing a promising avenue for future therapeutic strategies.

Current Market Potential and Prospects of Copper-based Pyridine Derivatives: A Review

Nicotine, minodronic acid, nicotinamide (niacin), zolpidem, zolimidine, and other pyridine-based chemicals play vital roles in medicine and biology. Pyridine-containing drugs are widely available on the market to treat a wide range of human ailments. As a result of these advances, pyridine research is continually expanding, and there are now higher expectations for how it may aid in the treatment of numerous ailments. This evaluation incorporates data acquired from sources, like PubMed, to provide a thorough summary of the approved drugs and bioactivity data for compounds containing pyridine. Most of the reactions discussed in this article will provide readers with a deeper understanding of various pyridine-related examples, which is necessary for the creation of copper catalysis-based synthetic processes that are more accessible, secure, environmentally friendly, and practical, and that also have higher accuracy and selectivity. This paper also discusses significant innovations in the multi-component copper-catalyzed synthesis of N-heterocycles (pyridine), with the aim of developing precise, cost-effective, and environmentally friendly oxygenation and oxidation synthetic methods for the future synthesis of additional novel pyridine base analogs. Therefore, the review article will serve as a novel platform for researchers investigating copper-based pyridine compounds.

Recent updates on transdermal drug delivery approaches for the management of gout and its clinical perspective

Oral and injectable drug administration have recently been replaced with transdermal drug delivery (TDD) approaches, which are less intrusive, less likely to be rejected by patients, and easier to administer. There is still room for improvement in the treatment of gout with the use of a TDD system. Gout has become a worldwide epidemic and a severe threat to human beings. Gout treatment can be accomplished in various ways, including orally and intravenously. Several traditional options are still useless, cumbersome, and potentially dangerous. Hence, gout therapeutic options are desperately required for more effective and less toxic drug delivery methods. Anti-gout medications using TDD could substantially influence obese people in the future, even if most trials are still in the animal stages. Thus, this review aimed to provide a concise overview of recent TDD technologies and anti-gout medication delivery methods that improved therapeutic efficacy and bioavailability. Moreover, clinical updates on investigational drugs have been discussed to address the potential findings against gout.

Review deciphering potent therapeutic approaches targeting Notch signaling pathway in breast cancer

In the current period of drug development, natural products have provided an unrivaled supply of anticancer medications. By modifying the cancer microenvironment and various signaling pathways, natural products and their derivatives and analogs play a significant role in cancer treatment. These substances are effective against several signaling pathways, particularly the cell death pathways (apoptosis and autophagy) and embryonic developmental pathways (Notch, Wnt, and Hedgehog pathways). Natural products have a long history, but more research is needed to understand their current function in the research and development of cancer treatments and the potential for natural products to serve as a significant source of therapeutic agents in the future. Several target-specific anticancer medications failed to treat cancer, necessitating research into natural compounds with multiple target properties. To help develop a better treatment plan for managing breast cancer, this review has outlined the anticancerous potential of several therapeutic approaches targeting the notch signaling system in breast tumors.

Cancer Proteomics for Cellular Dysfunction: Insights and Trends

BACKGROUND

Cancer is an ailment with having a very low survival rate globally. Poor cancer prognosis is primarily caused by the fact that people are found to have the disease when it is already well advanced. The goal of this study is to compile information on new avenues of investigation into biomarkers that may facilitate the routine detection of cancer. Proteomic analysis has recently developed into a crucial technique for cancer biology research, working in tandem with genomic analysis. Mass spectrometry techniques are one of several proteome analysis techniques that allow for the highly precise quantitative and qualitative recognition of hundreds of proteins in small quantities from various biological materials. These findings might soon serve as the foundation for better cancer diagnostic techniques.

METHODS

An exhaustive literature survey has been conducted using electronic databases such as Google Scholar, Science Direct, and PubMed with keywords of proteomics, applications of proteomics, the technology of proteomics, biomarkers, and patents related to biomarkers.

RESULT

Studies reported till 2021 focusing on cancer proteomics and the related patents have been included in the present review to obtain concrete findings, highlighting the applications of proteomics in cancer.

CONCLUSION

The present review aims to present the overview and insights into cancer proteomics, recent breakthroughs in proteomics techniques, and applications of proteomics with technological advancements, ranging from searching biomarkers to the characterization of molecular pathways, though the entire process is still in its infancy.

Exploring Synthesis and Chemotherapeutic Potential of Thiosemicarbazide Analogs

BACKGROUND

Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. Researchers are continually finding new and more effective medications to battle the diseases.

OBJECTIVE

The objective of this study is to identify the emerging role of Thiosemicarbazide analogs for different types of cancer targets with a glance at different novel synthetic routes reported for their synthesis.

METHODS

A systematic literature review was conducted from various sources over the last 15 years with the inclusion of published research and review articles that involves the synthesis and use of thiosemicarbazide analogs for different targets of cancer. Data from the literature review for synthesis and anticancer potential for specific targets for cancer studies of thiosemicarbazide analogs are summarized in the paper.

RESULTS

There are several emerging studies for new synthetic routes of thiosemicarbazide derivatives with their role in various types of cancers. The main limitation is the lack of clinical trial of the key findings for the emergence of new anticancer medication with thiosemicarbazide moiety.

CONCLUSION

Emerging therapies exist for use of a limited number of medications for the treatment of cancer; results of the ongoing studies will provide more robust evidence in the future.

In Silico Identification of HDAC Inhibitors for Multiple Myeloma: A Structure-based Virtual Screening, Drug Likeness, ADMET Profiling, Molecular Docking, and Molecular Dynamics Simulation Study

Background:

Multiple myeloma (MM) is a hematological malignancy of plasma cells that produce a monoclonal immunoglobulin protein. Despite significant advances in the treatment of MM, currently available therapies are associated with toxicity and resistance. As a result, there is an increasing demand for novel, effective therapeutics. Inhibition of histone deacetylases (HDACs) is emerging as a potential method for treating cancer. HDAC6 is one of 18 different HDAC isoforms that regulate tubulin lysine 40 and function in the microtubule network. HDAC6 participates in tumorigenesis and metastasis through protein ubiquitination, tubulin, and Hsp90. Several studies have found that inhibiting HDAC6 causes AKT and ERK dephosphorylation, which leads to decreased cell proliferation and promotes cancer cell death via the PI3K/AKT and MAPK/ERK signaling pathways.

Objective:

The objective of this study is to target HDAC6 and identify potent inhibitors for the treatment of multiple myeloma by employing computer-aided drug design.

Method:

A total of 199,611,439 molecules from five different chemical databases, such as CHEMBL25, ChemSpace, Mcule, MolPort, and ZINC, have been screened against HDAC6 by structure-based virtual screening, followed by filtering for various drug-likeness, ADME, toxicity, consensus molecular docking, and 100 ns MD simulation.

Results:

Our research work resulted in three molecules that have shown strong binding affinity (CHEMBL2425964 -9.99 kcal/mol, CHEMBL2425966 -9.89 kcal/mol, and CSC067477144 -9.86 kcal/mol) at the active site HDAC6, along with effective ADME properties, low toxicity, and high stability. Inhibiting HDAC6 with these identified molecules will induce AKT and ERK dephosphorylation linked to reduced cell proliferation and promote cancer cell death.

Conclusion:

CHEMBL2425964, CHEMBL2425966, and CSC067477144 could be effective against multiple myeloma.

An Insight into the Hepatoprotective Activity and Structure-activity Relationships of Flavonoids

BACKGROUND

Flavonoids are a class of polyphenolic bioactive compounds obtained from plants, which have a wide range of chemical structures and properties. More than 9000 distinct flavonoid molecules have been identified and have been found to regulate numerous developmental processes and play key biological roles in living organisms.

OBJECTIVE

This review aims to highlight the hepatoprotective potentiality of flavonoids and corelate their pharmacological activity with their chemical structure.

METHODS

With the advancement in the field of research related to phytochemicals, it is evident that flavonoids have versatile health benefits, viz., antioxidant property, free radical scavenging capacity, anticancer activity. The basic structures are C6-C3-C6 rings with various substitution patterns, resulting in a succession of subclass compounds, and the relationships between chemical structures and bioactivity have previously been investigated.

RESULTS

The hepatoprotective effects of bioactive flavonoids derived from plants have been widely linked to their antioxidant activity, antiinflammatory activity, effects on Sterol Regulatory Element- binding Proteins (SREBP), Peroxisome Proliferator-activated Receptor gamma (PPARγ) receptors, and inflammatory mediator cytokines according to numerous studies. The C2-C3 double bond at the A ring, as well as the hydroxyl groups of C3'or C4', and the carbonyl group at position C4, have been shown to augment their hepatoprotective activities; however, hydroxymethylation at C3' and C4' has been found to diminish the hepatoprotective activity.

CONCLUSION

The impact of flavonoid moieties and the structure-activity relationship of flavonoids related to combating various hepatic disorders have been vividly discussed in this review paper.

An Insight into Diverse Activities and Targets of Flavonoids

BACKGROUND

Flavonoids belong to the chemical class of polyphenols and are in the category of secondary metabolites imparting a wide protective effect against acute and chronic diseases.

OBJECTIVE

The study aims to investigate and summarize the information of various flavonoids extracted, isolated from various sources, and possess different pharmacological properties by acting on multiple targets.

METHODS

This comprehensive review summarizes the research information related to flavonoids and their pharmacological action targets from various sources like PubMed, Google Scholar and Google websites.

RESULTS

Extracted information in the paper discusses various therapeutic effects of flavonoids isolated from medicinal plant sources, which have the property to inhibit several enzymes, which finally results in health benefits like anti-cancer, anti-bacterial, antioxidant, anti-allergic, and anti-viral effects. This study also showed the different solvents and methods involved in the extraction and characterization of the isolated phytochemical constituents.

CONCLUSION

The findings showed the contribution of several flavonoids in the management and inhibition of various acute and chronic sicknesses by acting on different sites in the body. This study may lead to gaining interest for more research on the bioactives of different medicinal plants for the discovery of new lead compounds or further improvement of the efficacy of the existing compound.

Insight Into the various approaches for the enhancement of bioavailability and pharmacological potency of terpenoids: A Review

Abstract:

Terpenoids are naturally occurring secondary metabolites that consist of isoprene units (i.e., 2-methyl-1,3-butadiene). Terpenoids became recognized because of their diverse pharmacological benefits, such as anti-cancer, anti-inflammatory, antioxidant, analgesic, antibacterial, antifungal, hepatoprotective, antiviral, and antiparasitic activities. But most of these compounds have limited lipophilicity, dissolution rate, aqueous solubility, and drug permeability, so they are not used effectively. The low bioavailability significantly interferes with the performance of terpenoids to cure diseases, and the absorption process of terpenoids also becomes disrupted; therefore, their bioavailability in the blood becomes insufficient to achieve optimal treatment activity. Thus, to overcome this limitation, some strategies are used, such as nanotechnology (nanoparticles, carrier complexation), cocrystal, and glycosylation. Thus, this review summarizes the chemistry of terpenoids, factors that limit the bioavailability of terpenoids, and strategies employed to date with their design principles and outcomes possibly increasing their bioactivity.

Potential of Nanotechnology-based Formulations in Combating Pulmonary Infectious Diseases: A Current Scenario

BACKGROUND

Pulmonary microbial infection is mainly caused by microbes like atypical bacteria, viruses, and fungi, on both the upper and lower respiratory tracts. One of the demands of the present is the use of nanotechnology-based treatments to fight various lung infections.

AIM

The main aim of the study is to explore all pulmonary infectious diseases and to compare the advanced and novel treatment approaches with the conventional methods which are available to treat infections.

METHODS

This work sheds light on pulmonary infectious diseases with their conventional and present treatment approaches along with a focus on the advantageous roles of nano-based formulations. In the literature, it has been reported that the respiratory system is the key target of various infectious diseases which gives rise to various challenges in the treatment of pulmonary infections.

RESULTS

The present review article describes the global situation of pulmonary infections and the different strategies which are available for their management, along with their limitations. The article also highlights the advantages and different examples of nanoformulations currently combating the limitations of conventional therapies.

CONCLUSION

The content of the present article further reflects on the summary of recently published research and review works on pulmonary infections, conventional methods of treatment with their limitations, and the role of nano-based approaches to combat the existing infectious diseases which will jointly help the researchers to produce effective drug formulations with desired pharmacological activities.

A Brief Study on Drug Repurposing: New Way of Boosting Drug Discovery

Background:

Even with the massive increase in financial investments in pharmaceutical research over the last decade, the number of new drugs approved has plummeted. As a result, finding new uses for approved pharmaceuticals has become a prominent alternative approach for the pharmaceutical industry.

Objective:

Drug repurposing or repositioning is a game-changing development in the field of drug research that entails discovering additional uses for previously approved drugs.

Methods:

In comparison to traditional drug discovery methods, drug repositioning enhances the preclinical steps of creating innovative medications by reducing the cost and time of the process. Drug repositioning depends heavily on available drug-disease data, so the fast development of available data as well as developed computing skills has resulted in the boosting of various new drug repositioning methods. The main goal of this article is to describe these different methods and approaches for drug repurposing.

Results:

The article describes the basic concept of drug repurposing, its significance in discovering new medications for various disorders, drug repurposing approaches such as computational and experimental approaches, and previous as well as recent applications of drug repurposing in diseases such as cancer, COVID-19, and orphan diseases.

Conclusion:

The review also addresses obstacles in drug development using drug repurposing strategies, such as a lack of financing and regulatory concerns and concludes with outlining recommendations for overcoming these challenges.

Multiple Cancer Combating by Natural Bioactives: A Review

Background:

Significant progress in the field of anticancer research has led to a rise in the study of bioactive chemicals with potential anticancer effects. Still, many bioactive natural chemicals must be investigated in order to generate more effective anti-cancer therapeutics.

Outline:

There have been many attempts to treat cancer, and this review summarizes many bioactive substances obtained from nature that have the ability to fight against different types of malignancies with minimal harm, based on diverse research. Polyphenolic flavonoids, carotenoid (fucoxanthin), tannin, and other notable natural bioactive with anticancer potential were examined and reviewed systematically with an eye toward their significance in many types of cancer treatment.

Conclusion:

Throughout the text, it was concluded that the natural bioactive play a very prominent role in combating different types of cancer, and the information related to the bioactive role in cancer treatment over the last 10 years was gathered from several research and review articles. The material kept in this paper can act as a template for future research in expressing the more beneficial role of other bioactive in acting as an adjuvant in chemotherapy practice for prevention and treatment of various cancer additionally with no or minimal adverse effects which are prominent with the conventional drugs used for the treatment of cancer.

POS1495-HPR COVID-19, INFLUENZA AND PNEUMOCOCCUS VACCINATION UPTAKE IN PATIENTS WITH RHEUMATIC DISEASE: A PROSPECTIVE AUDIT

Background

Patients with autoimmune inflammatory rheumatic diseases are susceptible to infections. This could be attributed to theimmunosuppressive effect of the underlying condition or the use of immunomodulatory medications. According to the Department of Health guidelines inthe UK and the European League Against Rheumatism (EULAR), patients who are immunosuppressed should be vaccinated against influenza and pneumococcal infection, as well as COVID-19 infection.

Objectives

Our aim was to explore the Pneumococcal, Influenza and COVID-19 vaccination uptake of our patients with different autoimmune inflammatory rheumatological conditions. In addition, to assess the side effects profile and the status of their underlying rheumatological diseases following COVID-19 vaccination.

Methods

We undertook a prospective audit of consecutive patients with regards to their vaccination update for influenza, pneumococcus, and COVID-19, utilizing a standard questionnaire and compared the results to our 2017 data.

Results

Some 81% of patients received the influenza vaccination (compared to 47% in 2017) representing a 172% improvement, p<0.001. Some 53% received the pneumococcus vaccination compared to 28% in 2017, indicating a 185% improvement, p=0.003. With regards to COVID-19 vaccination, 98/101(97%) of eligible patients received at least one dose and 66% received two doses. 47% received Astra Zeneca, 52% Pfizer and 1% unsure. 46% of patients mentioned, no one specifically discussed the COVID vaccine with them - got information via SMS/ from media, However, 37% of patients were informed by GP Doctor/ Nurse, 14% from the person giving the vaccine, and 7% from specialist hospital doctor. Safety concerns were indicated by all 3 patients who deferred vaccination.

Most side-effects were observed following the first dose (74 patients) vs. the second dose (13 patients) and were mainly mild (66%), but also moderate (19%) and severe (15%). The sore arm was the commonest side-effect, whilst the majority of side-effects resolved within two days. Crucially, 28% reported a flare of the rheumatological condition following the vaccination. No patients receiving at least one dose were diagnosed with COVID-19 infection subsequently.

Conclusion

Vaccination rates for influenza and pneumococcus have improved substantially since 2017, although the population with rheumatic diseases still has low uptake in pneumococcal vaccination. The COVID-19 vaccination uptake has been extremely high in this cohort.

Disclosure of Interests

None declared

Nodding syndrome: A key role for sources of nutrition?

Nodding Syndrome (NS) has occurred among severely food-stressed communities in northern Uganda and several other East African populations that, with their forced physical displacement, have resorted to nutritional support from available wild plants and fungi, some of which have neurotoxic potential. Among the latter is an agaric mushroom with an unknown content of hydrazine-generating agaritine, namely Agaricus bingensis, the unusually wide consumption of which may relate to the low serum levels of vitamin B6 in Ugandan NS subjects relative to controls. Hydrazine-related compounds induce patterns of DNA damage that promote neuropathological changes (tauopathy) reminiscent of those associated with established NS. While the cause of this childhood brain disease is unknown, we encourage increased attention to the role of malnutrition and B6 hypovitaminosis in the etiology of this devastating brain disease.

•

Idiopathic epileptic encephalopathy with tauopathy (Nodding syndrome) impacts East African children

•

Associated factors include nematode infection, food insecurity, and food use of wild plants and fungi

•

Food use of hydrazinic fungi induces B6 hypovitaminosis, which may be marked in Nodding syndrome

•

Vitamin B6 deficiency promotes tau phosphorylation in mouse models of human tauopathy

•

Hydrazine generates carbon free radicals associated with DNA-damage and neurodegenerative disease

•

Increased research attention to nutritional practices associated with Nodding syndrome is merited.

In-Silico and In-Vitro Screening of Novel Pyridazine Analogs as Muscle Relaxant Agent on Acetylcholine Muscarinic Receptor

Background:

Among Nitrogen-containing heterocyclic compounds, pyridazine derivatives serve as a necessary scaffold as they possess various pharmacological activities. Thus, in recent times, the design of novel synthetic schemes and the selection of a new target for the action of pyridazine derivatives have attracted the attention of researchers.

Objective:

This study has focused on synthesizing and evaluating the muscle relaxant activity of pyridazine analogs by in-silico screening and rotarod test.

Methods:

In the present work, pyridazine derivatives were synthesized from substituted pyridine and maleic anhydride yielding intermediates (1a-5a) which on reaction with hydrazine yielded final pyridazine derivatives(1b-5b). They were then screened for muscle relaxant action by an in-silico docking study against muscarinic acetylcholine receptors with protein data bank ID: 5CXV with the use of Autodock 4.2 and Biovia discovery studio tools. Compounds were further tested for muscle relaxant activity by the rotarod test

Results:

Synthesis of the designed compounds was carried out successfully. Obtained result showed that the final compounds (1b-5b) showed 1-3 interactions with acetylcholine muscarinic receptor with -7.2 to -7.9 Kcal/mole affinities. The findings were compared to the typical drug diazepam, which has one interaction with the target and binding energy of -7.7 Kcal/mole. Moreover, the result of the rotarod test showed that substitution by electron-withdrawing groups causes more muscle relaxant activity when compared with the electron releasing groups

Conclusion:

The results of the experimental study showed that pyridazine derivatives could serve as a promising template for the further design and development of muscle relaxant agents.

Insights into Interactions of Human Cytochrome P450 17A1: Review

Abstract:

Cytochrome P450s are a widespread and vast superfamily of hemeprotein monooxygenases that metabolize physiologically essential chemicals necessary for most species' survival, from protists to plants to humans. They catalyze the synthesis of steroid hormones, cholesterol, bile acids, and arachidonate metabolites and the degradation of endogenous compounds such as steroids, fatty acids, and other catabolizing compounds as an energy source and detoxifying xenobiotics such as drugs, procarcinogens, and carcinogens. The human CYP17A1 is one of the cytochrome P450 genes located at the 10q chromosome. The gene expression occurs in the adrenals and gonads, with minor amounts in the brain, placenta, and heart. This P450c17 cytochrome gene is a critical steroidogenesis regulator which performs two distinct activities: 17 alpha-hydroxylase activity (converting pregnenolone to 17-hydroxypregnenolone and progesterone to 17-hydroxyprogesterone, these precursors are further processed to provide glucocorticoids and sex hormones) and 17, 20-lyase activity (which converts 17-hydroxypregnenolone to DHEA). Dozens of mutations within CYP17A1 are found to cause 17-alpha-hydroxylase and 17, 20-lyase deficiency. This condition affects the function of certain hormone-producing glands, resulting in high blood pressure levels (hypertension), abnormal sexual development, and other deficiency diseases. This review highlights the changes in CYP17A1 associated with gene-gene interaction, drug-gene interaction, chemical-gene interaction, and its biochemical reactions; they have some insights to correlate with the fascinating functional characteristics of this human steroidogenic gene. The findings of our theoretical results will be helpful to further the design of specific inhibitors of CYP17A1.

In Vitro and In Vivo Approaches for Screening the Potential of Anticancer Agents: A Review

BACKGROUND

Anticancer drug development is a tedious process, requiring several in vitro, in vivo, and clinical studies. In order to avoid chemical toxicity in animals during an experiment, it is necessary to envisage toxic doses of screened drugs in vivo at different concentrations. Several in vitro and in vivo studies have been reported to discover the management of cancer.

MATERIALS AND METHODS

This study focused on bringing together a wide range of in vivo and in vitro assay methods developed to evaluate each hallmark feature of cancer.

RESULT

This review provides detailed information on target-based and cell-based screening of new anticancer drugs in the molecular targeting period. This would help in inciting an alteration from the preclinical screening of pragmatic compound-orientated to target-orientated drug selection.

CONCLUSION

Selection methodologies for finding anticancer activity have importance for tumor- specific agents. In this study, advanced rationalization of the cell-based assay is explored along with broad applications of the cell-based methodologies considering other opportunities.

Development of Reverse Phase Ultra-fast Liquid Chromatography Using Ion-pairing Reagent for Quantitative Assessment of Ceftriaxone in Rat Serum and Cerebrospinal Fluid

Background:

In case of meningitis, the meninges are inflamed and the blood brain barrier is distorted, therefore, there is no hindrance to drug penetration. The problem arises when the disease is at the verge of cure, the meninges become uninflamed and the permeability of the drug is reduced to such extend that it becomes nearly impossible to maintain the minimum inhibitory concentration of drug at the site of infection. This problem was overcome by formulating ceftriaxone loaded NLCs and administrating it through intraperitoneal route to Wistar Albino rat. For quantitative assessment of drugs in rat serum and cerebrospinal spinal fluid, a new RP-UFLC (reverse-phase ultra-fast liquid chromatography) method has been developed and validated.

Objective:

Development and validation of RP-UFLC (using ion-pairing reagent) method for accurate estimation of ceftriaxone in rat serum and CSF.

Methods:

Method validation is done according to the ICH Guidelines (Q2) for the estimation of ceftriaxone in rat serum and its CSF (cerebrospinal fluid) by the RP-UFLC method. The blood was collected from the rat tail vein and CSF was collected carefully from cisterna magna of the rats by a 23G syringe. The mobile phase was used in a ratio of 70:30%v/v of phosphate buffer with ion-pairing reagent and acetonitrile with a pH of 8.0

Results:

Limit of detection and limit of quantification of ceftriaxone in rat serum was 1.08 μg/ml and 3.84 μg/ml, respectively. Similarly, the limit of detection and limit of quantification of ceftriaxone in CSF of rats was 0.94 μg/ml and 2.84 μg/ml, respectively. In both cases, the R2value was more than 0.99 and showed 99% accuracy.

Conclusion:

The experimental result suggests that the new RP-UFLC method developed and validated can be effectively used to assess ceftriaxone in preclinical studies in rats.

Elucidation of S-Allylcysteine Role in Inducing Apoptosis by Inhibiting PD-L1 Expression in Human Lung Cancer Cells

AIM

The aim of this study is to explore the therapeutic potential of S-allylcysteine (SAC) organosulphur compound as a potent immune checkpoint inhibitor PD-L1.

BACKGROUND

Natural compounds have been showing tremendous anticancerous potential via suppressing the expression of genes involved in the development and progression of several carcinomas. This has further motivated us to explore the therapeutic potential of organosulphur compounds as potent immune checkpoint inhibitors.

OBJECTIVE

Our study was designed to elucidate the potential of S-allylcysteine (SAC) as significant PD-L1 (immune checkpoint) inhibitor in human lung cancer A549 cancer cell line by using both the in vitro and in silico approaches.

METHODS

Anticancerous effect of the SAC on lung cancer cells was determined by using the MTT cell viability. Apoptotic induction was confirmed by Hoechst staining, percent caspase-3 activity as well as gene expression analysis by real time PCR. Reactive Oxygen Species (ROS) was estimated by DCFDA method. Additionally, ligand-target protein interaction was analysed by molecular docking.

RESULT

Cell growth and proliferation was significantly reduced in SAC treated A549 cells in a concentration and time.dependent manner. The effect of SAC on apoptotic induction was analyzed by enhanced nuclear condensation, increased percent caspase-3 activity as well as modulation of apoptotic genes. Furthermore, SAC treatment also resulted in reduced expression of PD-L1 and HIF-1α. Additionally, in silico analysis also supported the in vitro findings by showing efficient docking with PD-L1 immune checkpoint target.

CONCLUSION

Therefore, our results clearly suggested that SAC could serve as a novel chemotherapeutic candidate for the treatment of lung cancer by inhibiting immune checkpoint target PD-L1 in human lung cancer cells. Additionally, our study also explained a novel molecular mechanism of its antitumor activity.

Scanning window analysis of non-coding regions within normal-tumor whole-genome sequence samples

Genomics has benefited from an explosion in affordable high-throughput technology for whole-genome sequencing. The regulatory and functional aspects in non-coding regions may be an important contributor to oncogenesis. Whole-genome tumor-normal paired alignments were used to examine the non-coding regions in five cancer types and two races. Both a sliding window and a binning strategy were introduced to uncover areas of higher than expected variation for additional study. We show that the majority of cancer associated mutations in 154 whole-genome sequences covering breast invasive carcinoma, colon adenocarcinoma, kidney renal papillary cell carcinoma, lung adenocarcinoma and uterine corpus endometrial carcinoma cancers and two races are found outside of the coding region (4 432 885 in non-gene regions versus 1 412 731 in gene regions). A pan-cancer analysis found significantly mutated windows (292 to 3881 in count) demonstrating that there are significant numbers of large mutated regions in the non-coding genome. The 59 significantly mutated windows were found in all studied races and cancers. These offer 16 regions ripe for additional study within 12 different chromosomes-2, 4, 5, 7, 10, 11, 16, 18, 20, 21 and X. Many of these regions were found in centromeric locations. The X chromosome had the largest set of universal windows that cluster almost exclusively in Xq11.1-an area linked to chromosomal instability and oncogenesis. Large consecutive clusters (super windows) were found (19 to 114 in count) providing further evidence that large mutated regions in the genome are influencing cancer development. We show remarkable similarity in highly mutated non-coding regions across both cancer and race.

COVID-19 Biomarkers in research: Extension of the OncoMX cancer biomarker data model to capture biomarker data from other diseases

Scientists, medical researchers, and health care workers have mobilized worldwide in response to the outbreak of COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; SCoV2). Preliminary data have captured a wide range of host responses, symptoms, and lingering problems post-recovery within the human population. These variable clinical manifestations suggest differences in influential factors, such as innate and adaptive host immunity, existing or underlying health conditions, co-morbidities, genetics, and other factors. As COVID-19-related data continue to accumulate from disparate groups, the heterogeneous nature of these datasets poses challenges for efficient extrapolation of meaningful observations, hindering translation of information into clinical applications. Attempts to utilize, analyze, or combine biomarker datasets from multiple sources have shown to be inefficient and complicated, without a unifying resource. As such, there is an urgent need within the research community for the rapid development of an integrated and harmonized COVID-19 Biomarker Knowledgebase. By leveraging data collection and integration methods, backed by a robust data model developed to capture cancer biomarker data we have rapidly crowdsourced the collection and harmonization of COVID-19 biomarkers. Our resource currently has 138 unique biomarkers. We found multiple instances of the same biomarker substance being suggested as multiple biomarker types during our extensive cross-validation and manual curation. As a result, our Knowledgebase currently has 265 biomarker type combinations. Every biomarker entry is made comprehensive by bringing in together ancillary data from multiple sources such as biomarker accessions (canonical UniProtKB accession, PubChem Compound ID, Cell Ontology ID, Protein Ontology ID, NCI Thesaurus Code, and Disease Ontology ID), BEST biomarker category, and specimen type (Uberon Anatomy Ontology) unified with ontology standards. Our preliminary observations show distinct trends in the collated biomarkers. Most biomarkers are related to the immune system (SAA,TNF-∝, and IP-10) or coagulopathies (D-dimer, antithrombin, and VWF) and a few have already been established as cancer biomarkers (ACE2, IL-6, IL-4 and IL-2). These trends align with proposed hypotheses of clinical manifestations compounding the complexity of COVID-19 pathobiology. We explore these trends as we put forth a COVID-19 biomarker resource that will help researchers and diagnosticians alike. All biomarker data are freely available from https://data.oncomx.org/covid19 .

AB1178 AN AUDIT OF ORIGINATOR ADALIMUMAB TO BIOSIMILAR SWITCH IN TWO HOSPITALS

Background:

Biological drugs have revolutionized the treatment of immune-mediated inflammatory diseases (IMIDs). Current guidelines reserve these drugs for patients with severe refractory disease.

Biologic drugs are expensive, but as they reach patent expiry, the introduction of lower-cost biosimilars reduces their impact on health care budgets. It is estimated that NHS England could save £300 million by 2021 following the recent launch of adalimumab biosimilars [1]. As part of this process, there has been a mandatory switch of originator adalimumab to biosimilar adalimumab throughout the U.K.

Objectives:

To evaluate the impact of the switch to biosimilar adalimumab in individuals with inflammatory arthritis at two NHS trusts in the East of England and calculate the proportion and reasons for switch back to originator adalimumab or a second biosimilar at 12 weeks.

Methods:

Both hospitals ran dedicated ‘switch’ clinics. All patient records were reviewed retrospectively.

Results:

855 patients with different IMID switched from originator to biosimilar over 13 months. At 12 weeks, 730 patients (85%) maintained the switch, 71 patients (8.7%) switched back to the originator, and 54 patients (6.3%) switched to other biosimilars of the same drug.

Table 1.

Primary outcome analysis of switching from originator to adalimumab biosimilar

DiagnosisTotal patient switched from originatorAverage duration (year) of use of originator before bio switch (for patients continue using bio switch)Total patients continuing (At 12 weeks)Average duration (year) of use of originator before bio switch (for patients switched back to originator)Total patients switched back to originator or other biosimilarRheumatoid Arthritis3567.9314 (88%)4.942 (12%)Axial Spondyloarthritis2606.4213 (82%)4.547 (18%)Psoriatic Arthritis2185.9187 (86%)2.931 (14%)Juvenile Arthritis163.714 (88%)4.52 (12%)Others52.22 (40%)0.83 (60%)Total8557.0730 (85%)4.2125 (15%)Table 2.

Reasons for back to originator or another biosimilar

Reasons for back to originator or another biosimilarNumber back for IntoleranceNumber back for InefficacyPainful injection69BASDAI/Spinal Pain13Pain/Others19TJC, SJC, VAS4Rash/Allergic reaction5DAS3Headache5PsARC2Nausea4No Detail1Total102Total23%82%18%

Conclusion:

Switching to a biosimilar was successful in the vast majority of patients and is associated with significant saving. The list prices for originator Adalimumab is £9,155/person/year and £8,238/person/year for biosimilar Adalimumab respectively [2]. By switching we will save approximately £719,402 per annum (9.2% cost reduction).

References:

[1]NHS England. NHS set to save record £300 million on the NHS’s highest drug spend 2018 [cited 2018 November 30].https://www.england.nhs.uk/2018/11/nhs-set-to-save-record-300-million-on-the-nhss-highest-drug-spend/

[2]https://bnf.nice.org.uk/medicinal-forms/adalimumab.html

Disclosure of Interests:

Rifat Mazumder: None declared, Marianne Loke: None declared, Chetan Mukhtyar: None declared, Karl Gaffney Grant/research support from: AbbVie, Celgene, MSD, Novartis, Pfizer, and UCB Pharma, Consultant of: AbbVie, Celgene, MSD, Novartis, Pfizer, and UCB Pharma, Speakers bureau: AbbVie, Celgene, MSD, Novartis, Pfizer, and UCB Pharma, Emese Balogh: None declared, Emerald Sekaran: None declared, Mushfika Sultana: None declared, Mabel Odonkor: None declared, Karen Miles: None declared

Nodding syndrome phenotypes

Nodding syndrome (NS) is a progressive encephalopathy of children and adolescents characterized by seizures, including periodic vertical head nodding. Epidemic NS, which has affected parts of East Africa, appears to have clinical overlap with sub-Saharan Nakalanga syndrome (NLS), a brain disorder associated with pituitary dwarfism that appears to have a patchy distribution across sub-Sahara. Clinical stages of NS include inattention and blank stares, vertical head nodding, convulsive seizures, multiple impairments, and severe cognitive and motorsystem disability, including features suggesting parkinsonism. Head nodding episodes occur in clusters with an electrographic correlate of diffuse high-amplitude slow waves followed by an electrodecremental pattern with superimposed diffuse fast activity. Brain imaging reveals differing degrees of cerebral cortical and cerebellar atrophy. Brains of NS-affected children with mild frontotemporal cortical atrophy display neurofibrillary pathology and dystrophic neurites immunopositive for tau, consistent with a progressive neurodegenerative disorder. The etiology of NS and NLS appears to be dominated by environmental factors, including malnutrition, displacement, and nematode infection, but the specific cause is unknown.

Energy dependence of the transverse momentum distributions of charged particles in pp collisions measured by ALICE

Differential cross sections of charged particles in inelastic pp collisions as a function of p_T have been measured at [Formula: see text] at the LHC. The p_T spectra are compared to NLO-pQCD calculations. Though the differential cross section for an individual [Formula: see text] cannot be described by NLO-pQCD, the relative increase of cross section with [Formula: see text] is in agreement with NLO-pQCD. Based on these measurements and observations, procedures are discussed to construct pp reference spectra at [Formula: see text] up to p_T=50 GeV/c as required for the calculation of the nuclear modification factor in nucleus-nucleus and proton-nucleus collisions.

Directed flow of charged particles at midrapidity relative to the spectator plane in Pb-Pb collisions at √(s(NN))=2.76 TeV

The directed flow of charged particles at midrapidity is measured in Pb-Pb collisions at √(s(NN))=2.76 TeV relative to the collision symmetry plane defined by the spectator nucleons. A negative slope of the rapidity-odd directed flow component with approximately 3 times smaller magnitude than found at the highest RHIC energy is observed. This suggests a smaller longitudinal tilt of the initial system and disfavors the strong fireball rotation predicted for the LHC energies. The rapidity-even directed flow component is measured for the first time with spectators and found to be independent of pseudorapidity with a sign change at transverse momenta p(T) between 1.2 and 1.7  GeV/c. Combined with the observation of a vanishing rapidity-even p(T) shift along the spectator deflection this is strong evidence for dipolelike initial density fluctuations in the overlap zone of the nuclei. Similar trends in the rapidity-even directed flow and the estimate from two-particle correlations at midrapidity, which is larger by about a factor of 40, indicate a weak correlation between fluctuating participant and spectator symmetry planes. These observations open new possibilities for investigation of the initial conditions in heavy-ion collisions with spectator nucleons.

K(S)0 and Λ production in Pb-Pb collisions at √(s(NN))=2.76 TeV

The ALICE measurement of K(S)(0) and Λ production at midrapidity in Pb-Pb collisions at √(s(NN))=2.76 TeV is presented. The transverse momentum (p(T)) spectra are shown for several collision centrality intervals and in the p(T) range from 0.4 GeV/c (0.6 GeV/c for Λ) to 12 GeV/c. The p(T) dependence of the Λ/K(S)(0) ratios exhibits maxima in the vicinity of 3 GeV/c, and the positions of the maxima shift towards higher p(T) with increasing collision centrality. The magnitude of these maxima increases by almost a factor of three between most peripheral and most central Pb-Pb collisions. This baryon excess at intermediate p(T) is not observed in pp interactions at √s=0.9 TeV and at √s=7 TeV. Qualitatively, the baryon enhancement in heavy-ion collisions is expected from radial flow. However, the measured p(T) spectra above 2 GeV/c progressively decouple from hydrodynamical-model calculations. For higher values of p(T), models that incorporate the influence of the medium on the fragmentation and hadronization processes describe qualitatively the p(T) dependence of the Λ/K(S)(0) ratio.

Charmonium and e+e- pair photoproduction at mid-rapidity in ultra-peripheral Pb-Pb collisions at [Formula: see text]

The ALICE Collaboration at the LHC has measured the J/ψ and ψ' photoproduction at mid-rapidity in ultra-peripheral Pb-Pb collisions at [Formula: see text]. The charmonium is identified via its leptonic decay for events where the hadronic activity is required to be minimal. The analysis is based on an event sample corresponding to an integrated luminosity of about 23 μb-1. The cross section for coherent and incoherent J/ψ production in the rapidity interval -0.9 Collapse

Key Words Collapse

MESH Headings Collapse

Grants Collapse

Affiliation(s)

The ALICE Collaboration CERN, 1211 Geneva 23, Switzerland
E. Abbas Academy of Scientific Research and Technology (ASRT), Cairo, Egypt Fachhochschule Köln, Köln, Germany Department of Physics, Gauhati University, Guwahati, India Suranaree University of Technology, Nakhon Ratchasima, Thailand University of Technology and Austrian Academy of Sciences, Vienna, Austria
B. Abelev Lawrence Livermore National Laboratory, Livermore, California United States
J. Adam Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
D. Adamová Nuclear Physics Institute, Academy of Sciences of the Czech Republic, Řež u Prahy, Czech Republic
A. M. Adare Yale University, New Haven, Connecticut United States
M. M. Aggarwal Physics Department, Panjab University, Chandigarh, India
G. Aglieri Rinella European Organization for Nuclear Research (CERN), Geneva, Switzerland
M. Agnello Politecnico di Torino, Turin, Italy Sezione INFN, Turin, Italy
A. G. Agocs Wigner Research Centre for Physics, Hungarian Academy of Sciences, Budapest, Hungary
A. Agostinelli Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Bologna, Italy
Z. Ahammed Variable Energy Cyclotron Centre, Kolkata, India
N. Ahmad Department of Physics, Aligarh Muslim University, Aligarh, India
A. Ahmad Masoodi Department of Physics, Aligarh Muslim University, Aligarh, India
I. Ahmed COMSATS Institute of Information Technology (CIIT), Islamabad, Pakistan
S. A. Ahn Korea Institute of Science and Technology Information, Daejeon, South Korea
S. U. Ahn Korea Institute of Science and Technology Information, Daejeon, South Korea
I. Aimo Dipartimento di Fisica dell’Università and Sezione INFN, Turin, Italy Politecnico di Torino, Turin, Italy Sezione INFN, Turin, Italy
M. Ajaz COMSATS Institute of Information Technology (CIIT), Islamabad, Pakistan
A. Akindinov Institute for Theoretical and Experimental Physics, Moscow, Russia
D. Aleksandrov Russian Research Centre Kurchatov Institute, Moscow, Russia
B. Alessandro Sezione INFN, Turin, Italy
D. Alexandre School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
A. Alici Centro Fermi - Museo Storico della Fisica e Centro Studi e Ricerche “Enrico Fermi”, Rome, Italy Sezione INFN, Bologna, Italy
A. Alkin Bogolyubov Institute for Theoretical Physics, Kiev, Ukraine
E. Almaráz Aviña Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
J. Alme Faculty of Engineering, Bergen University College, Bergen, Norway
T. Alt Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
V. Altini Dipartimento Interateneo di Fisica ‘M. Merlin’ and Sezione INFN, Bari, Italy
S. Altinpinar Department of Physics and Technology, University of Bergen, Bergen, Norway
I. Altsybeev V. Fock Institute for Physics, St. Petersburg State University, St. Petersburg, Russia
C. Andrei National Institute for Physics and Nuclear Engineering, Bucharest, Romania
A. Andronic Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
V. Anguelov Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
J. Anielski Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, Münster, Germany
C. Anson Department of Physics, Ohio State University, Columbus, Ohio United States
T. Antičić Rudjer Bošković Institute, Zagreb, Croatia
F. Antinori Sezione INFN, Padova, Italy
P. Antonioli Sezione INFN, Bologna, Italy
L. Aphecetche SUBATECH, Ecole des Mines de Nantes, Université de Nantes, CNRS-IN2P3, Nantes, France
H. Appelshäuser Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
N. Arbor Laboratoire de Physique Subatomique et de Cosmologie (LPSC), Université Joseph Fourier, CNRS-IN2P3, Institut Polytechnique de Grenoble, Grenoble, France
S. Arcelli Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Bologna, Italy
A. Arend Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
N. Armesto Departamento de Física de Partículas and IGFAE, Universidad de Santiago de Compostela, Santiago de Compostela, Spain
R. Arnaldi Sezione INFN, Turin, Italy
T. Aronsson Yale University, New Haven, Connecticut United States
I. C. Arsene Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
M. Arslandok Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
A. Asryan V. Fock Institute for Physics, St. Petersburg State University, St. Petersburg, Russia
A. Augustinus European Organization for Nuclear Research (CERN), Geneva, Switzerland
R. Averbeck Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
T. C. Awes Oak Ridge National Laboratory, Oak Ridge, Tennessee United States
J. Äystö Helsinki Institute of Physics (HIP) and University of Jyväskylä, Jyväskylä, Finland
M. D. Azmi Department of Physics, Aligarh Muslim University, Aligarh, India Physics Department, University of Cape Town and iThemba LABS, National Research Foundation, Somerset West, South Africa
M. Bach Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
A. Badalà Sezione INFN, Catania, Italy
Y. W. Baek Gangneung-Wonju National University, Gangneung, South Korea Laboratoire de Physique Corpusculaire (LPC), Clermont Université, Université Blaise Pascal, CNRS–IN2P3, Clermont-Ferrand, France
R. Bailhache Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
R. Bala Physics Department, University of Jammu, Jammu, India Sezione INFN, Turin, Italy
A. Baldisseri Commissariat à l’Energie Atomique, IRFU, Saclay, France
F. Baltasar Dos Santos Pedrosa European Organization for Nuclear Research (CERN), Geneva, Switzerland
J. Bán Institute of Experimental Physics, Slovak Academy of Sciences, Košice, Slovakia
R. C. Baral Institute of Physics, Bhubaneswar, India
R. Barbera Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Catania, Italy
F. Barile Dipartimento Interateneo di Fisica ‘M. Merlin’ and Sezione INFN, Bari, Italy
G. G. Barnaföldi Wigner Research Centre for Physics, Hungarian Academy of Sciences, Budapest, Hungary
L. S. Barnby School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
V. Barret Laboratoire de Physique Corpusculaire (LPC), Clermont Université, Université Blaise Pascal, CNRS–IN2P3, Clermont-Ferrand, France
J. Bartke The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
M. Basile Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Bologna, Italy
N. Bastid Laboratoire de Physique Corpusculaire (LPC), Clermont Université, Université Blaise Pascal, CNRS–IN2P3, Clermont-Ferrand, France
S. Basu Variable Energy Cyclotron Centre, Kolkata, India
B. Bathen Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, Münster, Germany
G. Batigne SUBATECH, Ecole des Mines de Nantes, Université de Nantes, CNRS-IN2P3, Nantes, France
B. Batyunya Joint Institute for Nuclear Research (JINR), Dubna, Russia
P. C. Batzing Department of Physics, University of Oslo, Oslo, Norway
C. Baumann Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
I. G. Bearden Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
H. Beck Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
N. K. Behera Indian Institute of Technology Bombay (IIT), Mumbai, India
I. Belikov Institut Pluridisciplinaire Hubert Curien (IPHC), Université de Strasbourg, CNRS-IN2P3, Strasbourg, France
F. Bellini Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Bologna, Italy
R. Bellwied University of Houston, Houston, Texas United States
E. Belmont-Moreno Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
G. Bencedi Wigner Research Centre for Physics, Hungarian Academy of Sciences, Budapest, Hungary
S. Beole Dipartimento di Fisica dell’Università and Sezione INFN, Turin, Italy
I. Berceanu National Institute for Physics and Nuclear Engineering, Bucharest, Romania
A. Bercuci National Institute for Physics and Nuclear Engineering, Bucharest, Romania
Y. Berdnikov Petersburg Nuclear Physics Institute, Gatchina, Russia
D. Berenyi Wigner Research Centre for Physics, Hungarian Academy of Sciences, Budapest, Hungary
A. A. E. Bergognon SUBATECH, Ecole des Mines de Nantes, Université de Nantes, CNRS-IN2P3, Nantes, France
R. A. Bertens Nikhef, National Institute for Subatomic Physics and Institute for Subatomic Physics of Utrecht University, Utrecht, Netherlands
D. Berzano Dipartimento di Fisica dell’Università and Sezione INFN, Turin, Italy Sezione INFN, Turin, Italy
L. Betev European Organization for Nuclear Research (CERN), Geneva, Switzerland
A. Bhasin Physics Department, University of Jammu, Jammu, India
A. K. Bhati Physics Department, Panjab University, Chandigarh, India
J. Bhom University of Tsukuba, Tsukuba, Japan
L. Bianchi Dipartimento di Fisica dell’Università and Sezione INFN, Turin, Italy
N. Bianchi Laboratori Nazionali di Frascati, INFN, Frascati, Italy
C. Bianchin Nikhef, National Institute for Subatomic Physics and Institute for Subatomic Physics of Utrecht University, Utrecht, Netherlands
J. Bielčík Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
J. Bielčíková Nuclear Physics Institute, Academy of Sciences of the Czech Republic, Řež u Prahy, Czech Republic
A. Bilandzic Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
S. Bjelogrlic Nikhef, National Institute for Subatomic Physics and Institute for Subatomic Physics of Utrecht University, Utrecht, Netherlands
F. Blanco Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
F. Blanco University of Houston, Houston, Texas United States
D. Blau Russian Research Centre Kurchatov Institute, Moscow, Russia
C. Blume Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
M. Boccioli European Organization for Nuclear Research (CERN), Geneva, Switzerland
S. Böttger Institut für Informatik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
A. Bogdanov Moscow Engineering Physics Institute, Moscow, Russia
H. Bøggild Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
M. Bogolyubsky Institute for High Energy Physics, Protvino, Russia
L. Boldizsár Wigner Research Centre for Physics, Hungarian Academy of Sciences, Budapest, Hungary
M. Bombara Faculty of Science, P.J. Šafárik University, Košice, Slovakia
J. Book Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
H. Borel Commissariat à l’Energie Atomique, IRFU, Saclay, France
A. Borissov Wayne State University, Detroit, Michigan United States
F. Bossú Physics Department, University of Cape Town and iThemba LABS, National Research Foundation, Somerset West, South Africa
M. Botje Nikhef, National Institute for Subatomic Physics, Amsterdam, Netherlands
E. Botta Dipartimento di Fisica dell’Università and Sezione INFN, Turin, Italy
E. Braidot Lawrence Berkeley National Laboratory, Berkeley, California United States
P. Braun-Munzinger Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
M. Bregant SUBATECH, Ecole des Mines de Nantes, Université de Nantes, CNRS-IN2P3, Nantes, France
T. Breitner Institut für Informatik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
T. A. Broker Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
T. A. Browning Purdue University, West Lafayette, Indiana United States
M. Broz Faculty of Mathematics, Physics and Informatics, Comenius University, Bratislava, Slovakia
R. Brun European Organization for Nuclear Research (CERN), Geneva, Switzerland
E. Bruna Dipartimento di Fisica dell’Università and Sezione INFN, Turin, Italy Sezione INFN, Turin, Italy
G. E. Bruno Dipartimento Interateneo di Fisica ‘M. Merlin’ and Sezione INFN, Bari, Italy
D. Budnikov Russian Federal Nuclear Center (VNIIEF), Sarov, Russia
H. Buesching Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
S. Bufalino Dipartimento di Fisica dell’Università and Sezione INFN, Turin, Italy Sezione INFN, Turin, Italy
P. Buncic European Organization for Nuclear Research (CERN), Geneva, Switzerland
O. Busch Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
Z. Buthelezi Physics Department, University of Cape Town and iThemba LABS, National Research Foundation, Somerset West, South Africa
D. Caffarri Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Padova, Italy Sezione INFN, Padova, Italy
X. Cai Central China Normal University, Wuhan, China
H. Caines Yale University, New Haven, Connecticut United States
E. Calvo Villar Sección Física, Departamento de Ciencias, Pontificia Universidad Católica del Perú, Lima, Peru
P. Camerini Dipartimento di Fisica dell’Università and Sezione INFN, Trieste, Italy
V. Canoa Roman Centro de Investigación y de Estudios Avanzados (CINVESTAV), Mexico City and Mérida, Mexico
G. Cara Romeo Sezione INFN, Bologna, Italy
W. Carena European Organization for Nuclear Research (CERN), Geneva, Switzerland
F. Carena European Organization for Nuclear Research (CERN), Geneva, Switzerland
N. Carlin Filho Universidade de São Paulo (USP), São Paulo, Brazil
F. Carminati European Organization for Nuclear Research (CERN), Geneva, Switzerland
A. Casanova Díaz Laboratori Nazionali di Frascati, INFN, Frascati, Italy
J. Castillo Castellanos Commissariat à l’Energie Atomique, IRFU, Saclay, France
J. F. Castillo Hernandez Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
E. A. R. Casula Dipartimento di Fisica dell’Università and Sezione INFN, Cagliari, Italy
V. Catanescu National Institute for Physics and Nuclear Engineering, Bucharest, Romania
C. Cavicchioli European Organization for Nuclear Research (CERN), Geneva, Switzerland
C. Ceballos Sanchez Centro de Aplicaciones Tecnológicas y Desarrollo Nuclear (CEADEN), Havana, Cuba
J. Cepila Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
P. Cerello Sezione INFN, Turin, Italy
B. Chang Helsinki Institute of Physics (HIP) and University of Jyväskylä, Jyväskylä, Finland Yonsei University, Seoul, South Korea
S. Chapeland European Organization for Nuclear Research (CERN), Geneva, Switzerland
J. L. Charvet Commissariat à l’Energie Atomique, IRFU, Saclay, France
S. Chattopadhyay Variable Energy Cyclotron Centre, Kolkata, India
S. Chattopadhyay Saha Institute of Nuclear Physics, Kolkata, India
M. Cherney Physics Department, Creighton University, Omaha, Nebraska United States
C. Cheshkov European Organization for Nuclear Research (CERN), Geneva, Switzerland Université de Lyon, Université Lyon 1, CNRS/IN2P3, IPN-Lyon, Villeurbanne, France
B. Cheynis Université de Lyon, Université Lyon 1, CNRS/IN2P3, IPN-Lyon, Villeurbanne, France
V. Chibante Barroso European Organization for Nuclear Research (CERN), Geneva, Switzerland
D. D. Chinellato University of Houston, Houston, Texas United States
P. Chochula European Organization for Nuclear Research (CERN), Geneva, Switzerland
M. Chojnacki Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
S. Choudhury Variable Energy Cyclotron Centre, Kolkata, India
P. Christakoglou Nikhef, National Institute for Subatomic Physics, Amsterdam, Netherlands
C. H. Christensen Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
P. Christiansen Division of Experimental High Energy Physics, University of Lund, Lund, Sweden
T. Chujo University of Tsukuba, Tsukuba, Japan
S. U. Chung Pusan National University, Pusan, South Korea
C. Cicalo Sezione INFN, Cagliari, Italy
L. Cifarelli Centro Fermi - Museo Storico della Fisica e Centro Studi e Ricerche “Enrico Fermi”, Rome, Italy Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Bologna, Italy
F. Cindolo Sezione INFN, Bologna, Italy
J. Cleymans Physics Department, University of Cape Town and iThemba LABS, National Research Foundation, Somerset West, South Africa
F. Colamaria Dipartimento Interateneo di Fisica ‘M. Merlin’ and Sezione INFN, Bari, Italy
D. Colella Dipartimento Interateneo di Fisica ‘M. Merlin’ and Sezione INFN, Bari, Italy
A. Collu Dipartimento di Fisica dell’Università and Sezione INFN, Cagliari, Italy
G. Conesa Balbastre Laboratoire de Physique Subatomique et de Cosmologie (LPSC), Université Joseph Fourier, CNRS-IN2P3, Institut Polytechnique de Grenoble, Grenoble, France
Z. Conesa del Valle European Organization for Nuclear Research (CERN), Geneva, Switzerland Institut de Physique Nucléaire d’Orsay (IPNO), Université Paris-Sud, CNRS-IN2P3, Orsay, France
M. E. Connors Yale University, New Haven, Connecticut United States
G. Contin Dipartimento di Fisica dell’Università and Sezione INFN, Trieste, Italy
J. G. Contreras Centro de Investigación y de Estudios Avanzados (CINVESTAV), Mexico City and Mérida, Mexico
T. M. Cormier Wayne State University, Detroit, Michigan United States
Y. Corrales Morales Dipartimento di Fisica dell’Università and Sezione INFN, Turin, Italy
P. Cortese Dipartimento di Scienze e Innovazione Tecnologica dell’Università del Piemonte Orientale and Gruppo Collegato INFN, Alessandria, Italy
I. Cortés Maldonado Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
M. R. Cosentino Lawrence Berkeley National Laboratory, Berkeley, California United States
F. Costa European Organization for Nuclear Research (CERN), Geneva, Switzerland
M. E. Cotallo Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
E. Crescio Centro de Investigación y de Estudios Avanzados (CINVESTAV), Mexico City and Mérida, Mexico
P. Crochet Laboratoire de Physique Corpusculaire (LPC), Clermont Université, Université Blaise Pascal, CNRS–IN2P3, Clermont-Ferrand, France
E. Cruz Alaniz Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
R. Cruz Albino Centro de Investigación y de Estudios Avanzados (CINVESTAV), Mexico City and Mérida, Mexico
E. Cuautle Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City, Mexico
L. Cunqueiro Laboratori Nazionali di Frascati, INFN, Frascati, Italy
A. Dainese Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Padova, Italy Sezione INFN, Padova, Italy
R. Dang Central China Normal University, Wuhan, China
A. Danu Institute of Space Sciences (ISS), Bucharest, Romania
K. Das Saha Institute of Nuclear Physics, Kolkata, India
I. Das Institut de Physique Nucléaire d’Orsay (IPNO), Université Paris-Sud, CNRS-IN2P3, Orsay, France
S. Das Department of Physics and Centre for Astroparticle Physics and Space Science (CAPSS), Bose Institute, Kolkata, India
D. Das Saha Institute of Nuclear Physics, Kolkata, India
S. Dash Indian Institute of Technology Bombay (IIT), Mumbai, India
A. Dash Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil
S. De Variable Energy Cyclotron Centre, Kolkata, India
G. O. V. de Barros Universidade de São Paulo (USP), São Paulo, Brazil
A. De Caro Centro Fermi - Museo Storico della Fisica e Centro Studi e Ricerche “Enrico Fermi”, Rome, Italy Dipartimento di Fisica ‘E.R. Caianiello’ dell’Università and Gruppo Collegato INFN, Salerno, Italy
G. de Cataldo Sezione INFN, Bari, Italy
J. de Cuveland Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
A. De Falco Dipartimento di Fisica dell’Università and Sezione INFN, Cagliari, Italy
D. De Gruttola Centro Fermi - Museo Storico della Fisica e Centro Studi e Ricerche “Enrico Fermi”, Rome, Italy Dipartimento di Fisica ‘E.R. Caianiello’ dell’Università and Gruppo Collegato INFN, Salerno, Italy
H. Delagrange SUBATECH, Ecole des Mines de Nantes, Université de Nantes, CNRS-IN2P3, Nantes, France
A. Deloff National Centre for Nuclear Studies, Warsaw, Poland
N. De Marco Sezione INFN, Turin, Italy
E. Dénes Wigner Research Centre for Physics, Hungarian Academy of Sciences, Budapest, Hungary
S. De Pasquale Dipartimento di Fisica ‘E.R. Caianiello’ dell’Università and Gruppo Collegato INFN, Salerno, Italy
A. Deppman Universidade de São Paulo (USP), São Paulo, Brazil
G. D Erasmo Dipartimento Interateneo di Fisica ‘M. Merlin’ and Sezione INFN, Bari, Italy
R. de Rooij Nikhef, National Institute for Subatomic Physics and Institute for Subatomic Physics of Utrecht University, Utrecht, Netherlands
M. A. Diaz Corchero Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
D. Di Bari Dipartimento Interateneo di Fisica ‘M. Merlin’ and Sezione INFN, Bari, Italy
T. Dietel Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, Münster, Germany
C. Di Giglio Dipartimento Interateneo di Fisica ‘M. Merlin’ and Sezione INFN, Bari, Italy
S. Di Liberto Sezione INFN, Rome, Italy
A. Di Mauro European Organization for Nuclear Research (CERN), Geneva, Switzerland
P. Di Nezza Laboratori Nazionali di Frascati, INFN, Frascati, Italy
R. Divià European Organization for Nuclear Research (CERN), Geneva, Switzerland
Ø. Djuvsland Department of Physics and Technology, University of Bergen, Bergen, Norway
A. Dobrin Division of Experimental High Energy Physics, University of Lund, Lund, Sweden Nikhef, National Institute for Subatomic Physics and Institute for Subatomic Physics of Utrecht University, Utrecht, Netherlands Wayne State University, Detroit, Michigan United States
T. Dobrowolski National Centre for Nuclear Studies, Warsaw, Poland
B. Dönigus Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
O. Dordic Department of Physics, University of Oslo, Oslo, Norway
A. K. Dubey Variable Energy Cyclotron Centre, Kolkata, India
A. Dubla Nikhef, National Institute for Subatomic Physics and Institute for Subatomic Physics of Utrecht University, Utrecht, Netherlands
L. Ducroux Université de Lyon, Université Lyon 1, CNRS/IN2P3, IPN-Lyon, Villeurbanne, France
P. Dupieux Laboratoire de Physique Corpusculaire (LPC), Clermont Université, Université Blaise Pascal, CNRS–IN2P3, Clermont-Ferrand, France
A. K. Dutta Majumdar Saha Institute of Nuclear Physics, Kolkata, India
D. Elia Sezione INFN, Bari, Italy
D. Emschermann Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, Münster, Germany
H. Engel Institut für Informatik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
B. Erazmus European Organization for Nuclear Research (CERN), Geneva, Switzerland SUBATECH, Ecole des Mines de Nantes, Université de Nantes, CNRS-IN2P3, Nantes, France
H. A. Erdal Faculty of Engineering, Bergen University College, Bergen, Norway
D. Eschweiler Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
B. Espagnon Institut de Physique Nucléaire d’Orsay (IPNO), Université Paris-Sud, CNRS-IN2P3, Orsay, France
M. Estienne SUBATECH, Ecole des Mines de Nantes, Université de Nantes, CNRS-IN2P3, Nantes, France
S. Esumi University of Tsukuba, Tsukuba, Japan
D. Evans School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
S. Evdokimov Institute for High Energy Physics, Protvino, Russia
G. Eyyubova Department of Physics, University of Oslo, Oslo, Norway
D. Fabris Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Padova, Italy Sezione INFN, Padova, Italy
J. Faivre Laboratoire de Physique Subatomique et de Cosmologie (LPSC), Université Joseph Fourier, CNRS-IN2P3, Institut Polytechnique de Grenoble, Grenoble, France
D. Falchieri Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Bologna, Italy
A. Fantoni Laboratori Nazionali di Frascati, INFN, Frascati, Italy
M. Fasel Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
D. Fehlker Department of Physics and Technology, University of Bergen, Bergen, Norway
L. Feldkamp Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, Münster, Germany
D. Felea Institute of Space Sciences (ISS), Bucharest, Romania
A. Feliciello Sezione INFN, Turin, Italy
B. Fenton-Olsen Lawrence Berkeley National Laboratory, Berkeley, California United States
G. Feofilov V. Fock Institute for Physics, St. Petersburg State University, St. Petersburg, Russia
A. Fernández Téllez Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
A. Ferretti Dipartimento di Fisica dell’Università and Sezione INFN, Turin, Italy
A. Festanti Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Padova, Italy
J. Figiel The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
M. A. S. Figueredo Universidade de São Paulo (USP), São Paulo, Brazil
S. Filchagin Russian Federal Nuclear Center (VNIIEF), Sarov, Russia
D. Finogeev Institute for Nuclear Research, Academy of Sciences, Moscow, Russia
F. M. Fionda Dipartimento Interateneo di Fisica ‘M. Merlin’ and Sezione INFN, Bari, Italy
E. M. Fiore Dipartimento Interateneo di Fisica ‘M. Merlin’ and Sezione INFN, Bari, Italy
E. Floratos Physics Department, University of Athens, Athens, Greece
M. Floris European Organization for Nuclear Research (CERN), Geneva, Switzerland
S. Foertsch Physics Department, University of Cape Town and iThemba LABS, National Research Foundation, Somerset West, South Africa
P. Foka Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
S. Fokin Russian Research Centre Kurchatov Institute, Moscow, Russia
E. Fragiacomo Sezione INFN, Trieste, Italy
A. Francescon Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Padova, Italy European Organization for Nuclear Research (CERN), Geneva, Switzerland
U. Frankenfeld Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
U. Fuchs European Organization for Nuclear Research (CERN), Geneva, Switzerland
C. Furget Laboratoire de Physique Subatomique et de Cosmologie (LPSC), Université Joseph Fourier, CNRS-IN2P3, Institut Polytechnique de Grenoble, Grenoble, France
M. Fusco Girard Dipartimento di Fisica ‘E.R. Caianiello’ dell’Università and Gruppo Collegato INFN, Salerno, Italy
J. J. Gaardhøje Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
M. Gagliardi Dipartimento di Fisica dell’Università and Sezione INFN, Turin, Italy
A. Gago Sección Física, Departamento de Ciencias, Pontificia Universidad Católica del Perú, Lima, Peru
M. Gallio Dipartimento di Fisica dell’Università and Sezione INFN, Turin, Italy
D. R. Gangadharan Department of Physics, Ohio State University, Columbus, Ohio United States
P. Ganoti Oak Ridge National Laboratory, Oak Ridge, Tennessee United States
C. Garabatos Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
E. Garcia-Solis Chicago State University, Chicago, United States
C. Gargiulo European Organization for Nuclear Research (CERN), Geneva, Switzerland
I. Garishvili Lawrence Livermore National Laboratory, Livermore, California United States
J. Gerhard Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
M. Germain SUBATECH, Ecole des Mines de Nantes, Université de Nantes, CNRS-IN2P3, Nantes, France
C. Geuna Commissariat à l’Energie Atomique, IRFU, Saclay, France
M. Gheata European Organization for Nuclear Research (CERN), Geneva, Switzerland Institute of Space Sciences (ISS), Bucharest, Romania
A. Gheata European Organization for Nuclear Research (CERN), Geneva, Switzerland
B. Ghidini Dipartimento Interateneo di Fisica ‘M. Merlin’ and Sezione INFN, Bari, Italy
P. Ghosh Variable Energy Cyclotron Centre, Kolkata, India
P. Gianotti Laboratori Nazionali di Frascati, INFN, Frascati, Italy
P. Giubellino European Organization for Nuclear Research (CERN), Geneva, Switzerland
E. Gladysz-Dziadus The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
P. Glässel Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
R. Gomez Centro de Investigación y de Estudios Avanzados (CINVESTAV), Mexico City and Mérida, Mexico Universidad Autónoma de Sinaloa, Culiacán, Mexico
E. G. Ferreiro Departamento de Física de Partículas and IGFAE, Universidad de Santiago de Compostela, Santiago de Compostela, Spain
L. H. González-Trueba Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
P. González-Zamora Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
S. Gorbunov Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
A. Goswami Physics Department, University of Rajasthan, Jaipur, India
S. Gotovac Technical University of Split FESB, Split, Croatia
L. K. Graczykowski Warsaw University of Technology, Warsaw, Poland
R. Grajcarek Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
A. Grelli Nikhef, National Institute for Subatomic Physics and Institute for Subatomic Physics of Utrecht University, Utrecht, Netherlands
C. Grigoras European Organization for Nuclear Research (CERN), Geneva, Switzerland
A. Grigoras European Organization for Nuclear Research (CERN), Geneva, Switzerland
V. Grigoriev Moscow Engineering Physics Institute, Moscow, Russia
A. Grigoryan A. I. Alikhanyan National Science Laboratory (Yerevan Physics Institute) Foundation, Yerevan, Armenia
S. Grigoryan Joint Institute for Nuclear Research (JINR), Dubna, Russia
B. Grinyov Bogolyubov Institute for Theoretical Physics, Kiev, Ukraine
N. Grion Sezione INFN, Trieste, Italy
P. Gros Division of Experimental High Energy Physics, University of Lund, Lund, Sweden
J. F. Grosse-Oetringhaus European Organization for Nuclear Research (CERN), Geneva, Switzerland
J.-Y. Grossiord Université de Lyon, Université Lyon 1, CNRS/IN2P3, IPN-Lyon, Villeurbanne, France
R. Grosso European Organization for Nuclear Research (CERN), Geneva, Switzerland
F. Guber Institute for Nuclear Research, Academy of Sciences, Moscow, Russia
R. Guernane Laboratoire de Physique Subatomique et de Cosmologie (LPSC), Université Joseph Fourier, CNRS-IN2P3, Institut Polytechnique de Grenoble, Grenoble, France
B. Guerzoni Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Bologna, Italy
M. Guilbaud Université de Lyon, Université Lyon 1, CNRS/IN2P3, IPN-Lyon, Villeurbanne, France
K. Gulbrandsen Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
H. Gulkanyan A. I. Alikhanyan National Science Laboratory (Yerevan Physics Institute) Foundation, Yerevan, Armenia
T. Gunji University of Tokyo, Tokyo, Japan
A. Gupta Physics Department, University of Jammu, Jammu, India
R. Gupta Physics Department, University of Jammu, Jammu, India
R. Haake Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, Münster, Germany
Ø. Haaland Department of Physics and Technology, University of Bergen, Bergen, Norway
C. Hadjidakis Institut de Physique Nucléaire d’Orsay (IPNO), Université Paris-Sud, CNRS-IN2P3, Orsay, France
M. Haiduc Institute of Space Sciences (ISS), Bucharest, Romania
H. Hamagaki University of Tokyo, Tokyo, Japan
G. Hamar Wigner Research Centre for Physics, Hungarian Academy of Sciences, Budapest, Hungary
B. H. Han Department of Physics, Sejong University, Seoul, South Korea
L. D. Hanratty School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
A. Hansen Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
Z. Harmanová-Tóthová Faculty of Science, P.J. Šafárik University, Košice, Slovakia
J. W. Harris Yale University, New Haven, Connecticut United States
M. Hartig Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
A. Harton Chicago State University, Chicago, United States
D. Hatzifotiadou Sezione INFN, Bologna, Italy
S. Hayashi University of Tokyo, Tokyo, Japan
A. Hayrapetyan A. I. Alikhanyan National Science Laboratory (Yerevan Physics Institute) Foundation, Yerevan, Armenia European Organization for Nuclear Research (CERN), Geneva, Switzerland
S. T. Heckel Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
M. Heide Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, Münster, Germany
H. Helstrup Faculty of Engineering, Bergen University College, Bergen, Norway
A. Herghelegiu National Institute for Physics and Nuclear Engineering, Bucharest, Romania
G. Herrera Corral Centro de Investigación y de Estudios Avanzados (CINVESTAV), Mexico City and Mérida, Mexico
N. Herrmann Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
B. A. Hess Eberhard Karls Universität Tübingen, Tübingen, Germany
K. F. Hetland Faculty of Engineering, Bergen University College, Bergen, Norway
B. Hicks Yale University, New Haven, Connecticut United States
B. Hippolyte Institut Pluridisciplinaire Hubert Curien (IPHC), Université de Strasbourg, CNRS-IN2P3, Strasbourg, France
Y. Hori University of Tokyo, Tokyo, Japan
P. Hristov European Organization for Nuclear Research (CERN), Geneva, Switzerland
I. Hřivnáčová Institut de Physique Nucléaire d’Orsay (IPNO), Université Paris-Sud, CNRS-IN2P3, Orsay, France
M. Huang Department of Physics and Technology, University of Bergen, Bergen, Norway
T. J. Humanic Department of Physics, Ohio State University, Columbus, Ohio United States
D. S. Hwang Department of Physics, Sejong University, Seoul, South Korea
R. Ichou Laboratoire de Physique Corpusculaire (LPC), Clermont Université, Université Blaise Pascal, CNRS–IN2P3, Clermont-Ferrand, France
R. Ilkaev Russian Federal Nuclear Center (VNIIEF), Sarov, Russia
I. Ilkiv National Centre for Nuclear Studies, Warsaw, Poland
M. Inaba University of Tsukuba, Tsukuba, Japan
E. Incani Dipartimento di Fisica dell’Università and Sezione INFN, Cagliari, Italy
G. M. Innocenti Dipartimento di Fisica dell’Università and Sezione INFN, Turin, Italy
P. G. Innocenti European Organization for Nuclear Research (CERN), Geneva, Switzerland
M. Ippolitov Russian Research Centre Kurchatov Institute, Moscow, Russia
M. Irfan Department of Physics, Aligarh Muslim University, Aligarh, India
C. Ivan Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
M. Ivanov Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
A. Ivanov V. Fock Institute for Physics, St. Petersburg State University, St. Petersburg, Russia
V. Ivanov Petersburg Nuclear Physics Institute, Gatchina, Russia
O. Ivanytskyi Bogolyubov Institute for Theoretical Physics, Kiev, Ukraine
A. Jachołkowski Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Catania, Italy
P. M. Jacobs Lawrence Berkeley National Laboratory, Berkeley, California United States
C. Jahnke Universidade de São Paulo (USP), São Paulo, Brazil
H. J. Jang Korea Institute of Science and Technology Information, Daejeon, South Korea
M. A. Janik Warsaw University of Technology, Warsaw, Poland
P. H. S. Y. Jayarathna University of Houston, Houston, Texas United States
S. Jena Indian Institute of Technology Bombay (IIT), Mumbai, India
D. M. Jha Wayne State University, Detroit, Michigan United States
R. T. Jimenez Bustamante Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City, Mexico
P. G. Jones School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
H. Jung Gangneung-Wonju National University, Gangneung, South Korea
A. Jusko School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
A. B. Kaidalov Institute for Theoretical and Experimental Physics, Moscow, Russia
S. Kalcher Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
P. Kaliňák Institute of Experimental Physics, Slovak Academy of Sciences, Košice, Slovakia
T. Kalliokoski Helsinki Institute of Physics (HIP) and University of Jyväskylä, Jyväskylä, Finland
A. Kalweit European Organization for Nuclear Research (CERN), Geneva, Switzerland
J. H. Kang Yonsei University, Seoul, South Korea
V. Kaplin Moscow Engineering Physics Institute, Moscow, Russia
S. Kar Variable Energy Cyclotron Centre, Kolkata, India
A. Karasu Uysal European Organization for Nuclear Research (CERN), Geneva, Switzerland KTO Karatay University, Konya, Turkey Yildiz Technical University, Istanbul, Turkey
O. Karavichev Institute for Nuclear Research, Academy of Sciences, Moscow, Russia
T. Karavicheva Institute for Nuclear Research, Academy of Sciences, Moscow, Russia
E. Karpechev Institute for Nuclear Research, Academy of Sciences, Moscow, Russia
A. Kazantsev Russian Research Centre Kurchatov Institute, Moscow, Russia
U. Kebschull Institut für Informatik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
R. Keidel Zentrum für Technologietransfer und Telekommunikation (ZTT), Fachhochschule Worms, Worms, Germany
B. Ketzer Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany Technische Universität München, Munich, Germany
M. M. Khan Department of Physics, Aligarh Muslim University, Aligarh, India
P. Khan Saha Institute of Nuclear Physics, Kolkata, India
S. A. Khan Variable Energy Cyclotron Centre, Kolkata, India
K. H. Khan COMSATS Institute of Information Technology (CIIT), Islamabad, Pakistan
A. Khanzadeev Petersburg Nuclear Physics Institute, Gatchina, Russia
Y. Kharlov Institute for High Energy Physics, Protvino, Russia
B. Kileng Faculty of Engineering, Bergen University College, Bergen, Norway
M. Kim Yonsei University, Seoul, South Korea
T. Kim Yonsei University, Seoul, South Korea
B. Kim Yonsei University, Seoul, South Korea
S. Kim Department of Physics, Sejong University, Seoul, South Korea
M. Kim Gangneung-Wonju National University, Gangneung, South Korea
D. J. Kim Helsinki Institute of Physics (HIP) and University of Jyväskylä, Jyväskylä, Finland
J. S. Kim Gangneung-Wonju National University, Gangneung, South Korea
J. H. Kim Department of Physics, Sejong University, Seoul, South Korea
D. W. Kim Gangneung-Wonju National University, Gangneung, South Korea Korea Institute of Science and Technology Information, Daejeon, South Korea
S. Kirsch Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
I. Kisel Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
S. Kiselev Institute for Theoretical and Experimental Physics, Moscow, Russia
A. Kisiel Warsaw University of Technology, Warsaw, Poland
J. L. Klay California Polytechnic State University, San Luis Obispo, California United States
J. Klein Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
C. Klein-Bösing Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, Münster, Germany
M. Kliemant Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
A. Kluge European Organization for Nuclear Research (CERN), Geneva, Switzerland
M. L. Knichel Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
A. G. Knospe Physics Department, The University of Texas at Austin, Austin, TX United States
M. K. Köhler Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
T. Kollegger Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
A. Kolojvari V. Fock Institute for Physics, St. Petersburg State University, St. Petersburg, Russia
M. Kompaniets V. Fock Institute for Physics, St. Petersburg State University, St. Petersburg, Russia
V. Kondratiev V. Fock Institute for Physics, St. Petersburg State University, St. Petersburg, Russia
N. Kondratyeva Moscow Engineering Physics Institute, Moscow, Russia
A. Konevskikh Institute for Nuclear Research, Academy of Sciences, Moscow, Russia
V. Kovalenko V. Fock Institute for Physics, St. Petersburg State University, St. Petersburg, Russia
M. Kowalski The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
S. Kox Laboratoire de Physique Subatomique et de Cosmologie (LPSC), Université Joseph Fourier, CNRS-IN2P3, Institut Polytechnique de Grenoble, Grenoble, France
G. Koyithatta Meethaleveedu Indian Institute of Technology Bombay (IIT), Mumbai, India
J. Kral Helsinki Institute of Physics (HIP) and University of Jyväskylä, Jyväskylä, Finland
I. Králik Institute of Experimental Physics, Slovak Academy of Sciences, Košice, Slovakia
F. Kramer Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
A. Kravčáková Faculty of Science, P.J. Šafárik University, Košice, Slovakia
M. Krelina Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
M. Kretz Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
M. Krivda Institute of Experimental Physics, Slovak Academy of Sciences, Košice, Slovakia School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
F. Krizek Helsinki Institute of Physics (HIP) and University of Jyväskylä, Jyväskylä, Finland
M. Krus Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
E. Kryshen Petersburg Nuclear Physics Institute, Gatchina, Russia
M. Krzewicki Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
V. Kucera Nuclear Physics Institute, Academy of Sciences of the Czech Republic, Řež u Prahy, Czech Republic
Y. Kucheriaev Russian Research Centre Kurchatov Institute, Moscow, Russia
T. Kugathasan European Organization for Nuclear Research (CERN), Geneva, Switzerland
C. Kuhn Institut Pluridisciplinaire Hubert Curien (IPHC), Université de Strasbourg, CNRS-IN2P3, Strasbourg, France
P. G. Kuijer Nikhef, National Institute for Subatomic Physics, Amsterdam, Netherlands
I. Kulakov Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
J. Kumar Indian Institute of Technology Bombay (IIT), Mumbai, India
P. Kurashvili National Centre for Nuclear Studies, Warsaw, Poland
A. Kurepin Institute for Nuclear Research, Academy of Sciences, Moscow, Russia
A. B. Kurepin Institute for Nuclear Research, Academy of Sciences, Moscow, Russia
A. Kuryakin Russian Federal Nuclear Center (VNIIEF), Sarov, Russia
V. Kushpil Nuclear Physics Institute, Academy of Sciences of the Czech Republic, Řež u Prahy, Czech Republic
S. Kushpil Nuclear Physics Institute, Academy of Sciences of the Czech Republic, Řež u Prahy, Czech Republic
H. Kvaerno Department of Physics, University of Oslo, Oslo, Norway
M. J. Kweon Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
Y. Kwon Yonsei University, Seoul, South Korea
P. Ladrón de Guevara Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City, Mexico
C. Lagana Fernandes Universidade de São Paulo (USP), São Paulo, Brazil
I. Lakomov Institut de Physique Nucléaire d’Orsay (IPNO), Université Paris-Sud, CNRS-IN2P3, Orsay, France
R. Langoy Department of Physics and Technology, University of Bergen, Bergen, Norway Vestfold University College, Tonsberg, Norway
S. L. La Pointe Nikhef, National Institute for Subatomic Physics and Institute for Subatomic Physics of Utrecht University, Utrecht, Netherlands
C. Lara Institut für Informatik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
A. Lardeux SUBATECH, Ecole des Mines de Nantes, Université de Nantes, CNRS-IN2P3, Nantes, France
P. La Rocca Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Catania, Italy
R. Lea Dipartimento di Fisica dell’Università and Sezione INFN, Trieste, Italy
M. Lechman European Organization for Nuclear Research (CERN), Geneva, Switzerland
S. C. Lee Gangneung-Wonju National University, Gangneung, South Korea
G. R. Lee School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
I. Legrand European Organization for Nuclear Research (CERN), Geneva, Switzerland
J. Lehnert Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
R. C. Lemmon Nuclear Physics Group, STFC Daresbury Laboratory, Daresbury, United Kingdom
M. Lenhardt Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
V. Lenti Sezione INFN, Bari, Italy
H. León Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
M. Leoncino Dipartimento di Fisica dell’Università and Sezione INFN, Turin, Italy
I. León Monzón Universidad Autónoma de Sinaloa, Culiacán, Mexico
P. Lévai Wigner Research Centre for Physics, Hungarian Academy of Sciences, Budapest, Hungary
S. Li Central China Normal University, Wuhan, China Laboratoire de Physique Corpusculaire (LPC), Clermont Université, Université Blaise Pascal, CNRS–IN2P3, Clermont-Ferrand, France
J. Lien Department of Physics and Technology, University of Bergen, Bergen, Norway Vestfold University College, Tonsberg, Norway
R. Lietava School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
S. Lindal Department of Physics, University of Oslo, Oslo, Norway
V. Lindenstruth Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
C. Lippmann European Organization for Nuclear Research (CERN), Geneva, Switzerland Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
M. A. Lisa Department of Physics, Ohio State University, Columbus, Ohio United States
H. M. Ljunggren Division of Experimental High Energy Physics, University of Lund, Lund, Sweden
D. F. Lodato Nikhef, National Institute for Subatomic Physics and Institute for Subatomic Physics of Utrecht University, Utrecht, Netherlands
P. I. Loenne Department of Physics and Technology, University of Bergen, Bergen, Norway
V. R. Loggins Wayne State University, Detroit, Michigan United States
V. Loginov Moscow Engineering Physics Institute, Moscow, Russia
D. Lohner Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
C. Loizides Lawrence Berkeley National Laboratory, Berkeley, California United States
K. K. Loo Helsinki Institute of Physics (HIP) and University of Jyväskylä, Jyväskylä, Finland
X. Lopez Laboratoire de Physique Corpusculaire (LPC), Clermont Université, Université Blaise Pascal, CNRS–IN2P3, Clermont-Ferrand, France
E. López Torres Centro de Aplicaciones Tecnológicas y Desarrollo Nuclear (CEADEN), Havana, Cuba
G. Løvhøiden Department of Physics, University of Oslo, Oslo, Norway
X.-G. Lu Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
P. Luettig Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
M. Lunardon Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Padova, Italy
J. Luo Central China Normal University, Wuhan, China
G. Luparello Nikhef, National Institute for Subatomic Physics and Institute for Subatomic Physics of Utrecht University, Utrecht, Netherlands
C. Luzzi European Organization for Nuclear Research (CERN), Geneva, Switzerland
R. Ma Yale University, New Haven, Connecticut United States
K. Ma Central China Normal University, Wuhan, China
D. M. Madagodahettige-Don University of Houston, Houston, Texas United States
A. Maevskaya Institute for Nuclear Research, Academy of Sciences, Moscow, Russia
M. Mager European Organization for Nuclear Research (CERN), Geneva, Switzerland Institut für Kernphysik, Technische Universität Darmstadt, Darmstadt, Germany
D. P. Mahapatra Institute of Physics, Bhubaneswar, India
A. Maire Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
M. Malaev Petersburg Nuclear Physics Institute, Gatchina, Russia
I. Maldonado Cervantes Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City, Mexico
L. Malinina Joint Institute for Nuclear Research (JINR), Dubna, Russia
D. Mal’Kevich Institute for Theoretical and Experimental Physics, Moscow, Russia
P. Malzacher Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
A. Mamonov Russian Federal Nuclear Center (VNIIEF), Sarov, Russia
L. Manceau Sezione INFN, Turin, Italy
L. Mangotra Physics Department, University of Jammu, Jammu, India
V. Manko Russian Research Centre Kurchatov Institute, Moscow, Russia
F. Manso Laboratoire de Physique Corpusculaire (LPC), Clermont Université, Université Blaise Pascal, CNRS–IN2P3, Clermont-Ferrand, France
V. Manzari Sezione INFN, Bari, Italy
Y. Mao Central China Normal University, Wuhan, China
M. Marchisone Dipartimento di Fisica dell’Università and Sezione INFN, Turin, Italy Laboratoire de Physique Corpusculaire (LPC), Clermont Université, Université Blaise Pascal, CNRS–IN2P3, Clermont-Ferrand, France
J. Mareš Institute of Physics, Academy of Sciences of the Czech Republic, Prague, Czech Republic
G. V. Margagliotti Dipartimento di Fisica dell’Università and Sezione INFN, Trieste, Italy Sezione INFN, Trieste, Italy
A. Margotti Sezione INFN, Bologna, Italy
A. Marín Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
C. Markert Physics Department, The University of Texas at Austin, Austin, TX United States
M. Marquard Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
I. Martashvili University of Tennessee, Knoxville, Tennessee United States
N. A. Martin Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
P. Martinengo European Organization for Nuclear Research (CERN), Geneva, Switzerland
M. I. Martínez Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
G. Martínez García SUBATECH, Ecole des Mines de Nantes, Université de Nantes, CNRS-IN2P3, Nantes, France
Y. Martynov Bogolyubov Institute for Theoretical Physics, Kiev, Ukraine
A. Mas SUBATECH, Ecole des Mines de Nantes, Université de Nantes, CNRS-IN2P3, Nantes, France
S. Masciocchi Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
M. Masera Dipartimento di Fisica dell’Università and Sezione INFN, Turin, Italy
A. Masoni Sezione INFN, Cagliari, Italy
L. Massacrier SUBATECH, Ecole des Mines de Nantes, Université de Nantes, CNRS-IN2P3, Nantes, France
A. Mastroserio Dipartimento Interateneo di Fisica ‘M. Merlin’ and Sezione INFN, Bari, Italy
A. Matyja The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
C. Mayer The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
J. Mazer University of Tennessee, Knoxville, Tennessee United States
R. Mazumder Indian Institute of Technology Indore (IITI), Indore, India
M. A. Mazzoni Sezione INFN, Rome, Italy
F. Meddi Dipartimento di Fisica dell’Università ‘La Sapienza’ and Sezione INFN, Rome, Italy
A. Menchaca-Rocha Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
J. Mercado Pérez Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
M. Meres Faculty of Mathematics, Physics and Informatics, Comenius University, Bratislava, Slovakia
Y. Miake University of Tsukuba, Tsukuba, Japan
K. Mikhaylov Institute for Theoretical and Experimental Physics, Moscow, Russia Joint Institute for Nuclear Research (JINR), Dubna, Russia
L. Milano Dipartimento di Fisica dell’Università and Sezione INFN, Turin, Italy European Organization for Nuclear Research (CERN), Geneva, Switzerland
J. Milosevic Department of Physics, University of Oslo, Oslo, Norway
A. Mischke Nikhef, National Institute for Subatomic Physics and Institute for Subatomic Physics of Utrecht University, Utrecht, Netherlands
A. N. Mishra Indian Institute of Technology Indore (IITI), Indore, India Physics Department, University of Rajasthan, Jaipur, India
D. Miśkowiec Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
C. Mitu Institute of Space Sciences (ISS), Bucharest, Romania
S. Mizuno University of Tsukuba, Tsukuba, Japan
J. Mlynarz Wayne State University, Detroit, Michigan United States
B. Mohanty National Institute of Science Education and Research, Bhubaneswar, India Variable Energy Cyclotron Centre, Kolkata, India
L. Molnar Institut Pluridisciplinaire Hubert Curien (IPHC), Université de Strasbourg, CNRS-IN2P3, Strasbourg, France Wigner Research Centre for Physics, Hungarian Academy of Sciences, Budapest, Hungary
L. Montaño Zetina Centro de Investigación y de Estudios Avanzados (CINVESTAV), Mexico City and Mérida, Mexico
M. Monteno Sezione INFN, Turin, Italy
E. Montes Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
T. Moon Yonsei University, Seoul, South Korea
M. Morando Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Padova, Italy
D. A. Moreira De Godoy Universidade de São Paulo (USP), São Paulo, Brazil
S. Moretto Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Padova, Italy
A. Morreale Helsinki Institute of Physics (HIP) and University of Jyväskylä, Jyväskylä, Finland
A. Morsch European Organization for Nuclear Research (CERN), Geneva, Switzerland
V. Muccifora Laboratori Nazionali di Frascati, INFN, Frascati, Italy
E. Mudnic Technical University of Split FESB, Split, Croatia
S. Muhuri Variable Energy Cyclotron Centre, Kolkata, India
M. Mukherjee Variable Energy Cyclotron Centre, Kolkata, India
H. Müller European Organization for Nuclear Research (CERN), Geneva, Switzerland
M. G. Munhoz Universidade de São Paulo (USP), São Paulo, Brazil
S. Murray Physics Department, University of Cape Town and iThemba LABS, National Research Foundation, Somerset West, South Africa
L. Musa European Organization for Nuclear Research (CERN), Geneva, Switzerland
J. Musinsky Institute of Experimental Physics, Slovak Academy of Sciences, Košice, Slovakia
B. K. Nandi Indian Institute of Technology Bombay (IIT), Mumbai, India
R. Nania Sezione INFN, Bologna, Italy
E. Nappi Sezione INFN, Bari, Italy
C. Nattrass University of Tennessee, Knoxville, Tennessee United States
T. K. Nayak Variable Energy Cyclotron Centre, Kolkata, India
S. Nazarenko Russian Federal Nuclear Center (VNIIEF), Sarov, Russia
A. Nedosekin Institute for Theoretical and Experimental Physics, Moscow, Russia
M. Nicassio Dipartimento Interateneo di Fisica ‘M. Merlin’ and Sezione INFN, Bari, Italy Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
M. Niculescu European Organization for Nuclear Research (CERN), Geneva, Switzerland Institute of Space Sciences (ISS), Bucharest, Romania
B. S. Nielsen Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
T. Niida University of Tsukuba, Tsukuba, Japan
S. Nikolaev Russian Research Centre Kurchatov Institute, Moscow, Russia
V. Nikolic Rudjer Bošković Institute, Zagreb, Croatia
S. Nikulin Russian Research Centre Kurchatov Institute, Moscow, Russia
V. Nikulin Petersburg Nuclear Physics Institute, Gatchina, Russia
B. S. Nilsen Physics Department, Creighton University, Omaha, Nebraska United States
M. S. Nilsson Department of Physics, University of Oslo, Oslo, Norway
F. Noferini Centro Fermi - Museo Storico della Fisica e Centro Studi e Ricerche “Enrico Fermi”, Rome, Italy Sezione INFN, Bologna, Italy
P. Nomokonov Joint Institute for Nuclear Research (JINR), Dubna, Russia
G. Nooren Nikhef, National Institute for Subatomic Physics and Institute for Subatomic Physics of Utrecht University, Utrecht, Netherlands
A. Nyanin Russian Research Centre Kurchatov Institute, Moscow, Russia
A. Nyatha Indian Institute of Technology Bombay (IIT), Mumbai, India
C. Nygaard Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
J. Nystrand Department of Physics and Technology, University of Bergen, Bergen, Norway
A. Ochirov V. Fock Institute for Physics, St. Petersburg State University, St. Petersburg, Russia
H. Oeschler European Organization for Nuclear Research (CERN), Geneva, Switzerland Institut für Kernphysik, Technische Universität Darmstadt, Darmstadt, Germany Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
S. Oh Yale University, New Haven, Connecticut United States
S. K. Oh Gangneung-Wonju National University, Gangneung, South Korea
J. Oleniacz Warsaw University of Technology, Warsaw, Poland
A. C. Oliveira Da Silva Universidade de São Paulo (USP), São Paulo, Brazil
J. Onderwaater Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
C. Oppedisano Sezione INFN, Turin, Italy
A. Ortiz Velasquez Division of Experimental High Energy Physics, University of Lund, Lund, Sweden Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City, Mexico
A. Oskarsson Division of Experimental High Energy Physics, University of Lund, Lund, Sweden
P. Ostrowski Warsaw University of Technology, Warsaw, Poland
J. Otwinowski Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
K. Oyama Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
K. Ozawa University of Tokyo, Tokyo, Japan
Y. Pachmayer Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
M. Pachr Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
F. Padilla Dipartimento di Fisica dell’Università and Sezione INFN, Turin, Italy
P. Pagano Dipartimento di Fisica ‘E.R. Caianiello’ dell’Università and Gruppo Collegato INFN, Salerno, Italy
G. Paić Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City, Mexico
F. Painke Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
C. Pajares Departamento de Física de Partículas and IGFAE, Universidad de Santiago de Compostela, Santiago de Compostela, Spain
S. K. Pal Variable Energy Cyclotron Centre, Kolkata, India
A. Palaha School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
A. Palmeri Sezione INFN, Catania, Italy
V. Papikyan A. I. Alikhanyan National Science Laboratory (Yerevan Physics Institute) Foundation, Yerevan, Armenia
G. S. Pappalardo Sezione INFN, Catania, Italy
W. J. Park Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
A. Passfeld Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, Münster, Germany
D. I. Patalakha Institute for High Energy Physics, Protvino, Russia
V. Paticchio Sezione INFN, Bari, Italy
B. Paul Saha Institute of Nuclear Physics, Kolkata, India
A. Pavlinov Wayne State University, Detroit, Michigan United States
T. Pawlak Warsaw University of Technology, Warsaw, Poland
T. Peitzmann Nikhef, National Institute for Subatomic Physics and Institute for Subatomic Physics of Utrecht University, Utrecht, Netherlands
H. Pereira Da Costa Commissariat à l’Energie Atomique, IRFU, Saclay, France
E. Pereira De Oliveira Filho Universidade de São Paulo (USP), São Paulo, Brazil
D. Peresunko Russian Research Centre Kurchatov Institute, Moscow, Russia
C. E. Pérez Lara Nikhef, National Institute for Subatomic Physics, Amsterdam, Netherlands
D. Perrino Dipartimento Interateneo di Fisica ‘M. Merlin’ and Sezione INFN, Bari, Italy
W. Peryt Warsaw University of Technology, Warsaw, Poland
A. Pesci Sezione INFN, Bologna, Italy
Y. Pestov Budker Institute for Nuclear Physics, Novosibirsk, Russia
V. Petráček Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
M. Petran Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
M. Petris National Institute for Physics and Nuclear Engineering, Bucharest, Romania
P. Petrov School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
M. Petrovici National Institute for Physics and Nuclear Engineering, Bucharest, Romania
C. Petta Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Catania, Italy
S. Piano Sezione INFN, Trieste, Italy
M. Pikna Faculty of Mathematics, Physics and Informatics, Comenius University, Bratislava, Slovakia
P. Pillot SUBATECH, Ecole des Mines de Nantes, Université de Nantes, CNRS-IN2P3, Nantes, France
O. Pinazza European Organization for Nuclear Research (CERN), Geneva, Switzerland
L. Pinsky University of Houston, Houston, Texas United States
N. Pitz Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
D. B. Piyarathna University of Houston, Houston, Texas United States
M. Planinic Rudjer Bošković Institute, Zagreb, Croatia
M. Płoskoń Lawrence Berkeley National Laboratory, Berkeley, California United States
J. Pluta Warsaw University of Technology, Warsaw, Poland
T. Pocheptsov Joint Institute for Nuclear Research (JINR), Dubna, Russia
S. Pochybova Wigner Research Centre for Physics, Hungarian Academy of Sciences, Budapest, Hungary
P. L. M. Podesta-Lerma Universidad Autónoma de Sinaloa, Culiacán, Mexico
M. G. Poghosyan European Organization for Nuclear Research (CERN), Geneva, Switzerland
K. Polák Institute of Physics, Academy of Sciences of the Czech Republic, Prague, Czech Republic
B. Polichtchouk Institute for High Energy Physics, Protvino, Russia
N. Poljak Nikhef, National Institute for Subatomic Physics and Institute for Subatomic Physics of Utrecht University, Utrecht, Netherlands Rudjer Bošković Institute, Zagreb, Croatia
A. Pop National Institute for Physics and Nuclear Engineering, Bucharest, Romania
S. Porteboeuf-Houssais Laboratoire de Physique Corpusculaire (LPC), Clermont Université, Université Blaise Pascal, CNRS–IN2P3, Clermont-Ferrand, France
V. Pospíšil Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
B. Potukuchi Physics Department, University of Jammu, Jammu, India
S. K. Prasad Wayne State University, Detroit, Michigan United States
R. Preghenella Centro Fermi - Museo Storico della Fisica e Centro Studi e Ricerche “Enrico Fermi”, Rome, Italy Sezione INFN, Bologna, Italy
F. Prino Sezione INFN, Turin, Italy
C. A. Pruneau Wayne State University, Detroit, Michigan United States
I. Pshenichnov Institute for Nuclear Research, Academy of Sciences, Moscow, Russia
G. Puddu Dipartimento di Fisica dell’Università and Sezione INFN, Cagliari, Italy
V. Punin Russian Federal Nuclear Center (VNIIEF), Sarov, Russia
J. Putschke Wayne State University, Detroit, Michigan United States
H. Qvigstad Department of Physics, University of Oslo, Oslo, Norway
A. Rachevski Sezione INFN, Trieste, Italy
A. Rademakers European Organization for Nuclear Research (CERN), Geneva, Switzerland
T. S. Räihä Helsinki Institute of Physics (HIP) and University of Jyväskylä, Jyväskylä, Finland
J. Rak Helsinki Institute of Physics (HIP) and University of Jyväskylä, Jyväskylä, Finland
A. Rakotozafindrabe Commissariat à l’Energie Atomique, IRFU, Saclay, France
L. Ramello Dipartimento di Scienze e Innovazione Tecnologica dell’Università del Piemonte Orientale and Gruppo Collegato INFN, Alessandria, Italy
S. Raniwala Physics Department, University of Rajasthan, Jaipur, India
R. Raniwala Physics Department, University of Rajasthan, Jaipur, India
S. S. Räsänen Helsinki Institute of Physics (HIP) and University of Jyväskylä, Jyväskylä, Finland
B. T. Rascanu Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
D. Rathee Physics Department, Panjab University, Chandigarh, India
W. Rauch European Organization for Nuclear Research (CERN), Geneva, Switzerland
A. W. Rauf COMSATS Institute of Information Technology (CIIT), Islamabad, Pakistan
V. Razazi Dipartimento di Fisica dell’Università and Sezione INFN, Cagliari, Italy
K. F. Read University of Tennessee, Knoxville, Tennessee United States
J. S. Real Laboratoire de Physique Subatomique et de Cosmologie (LPSC), Université Joseph Fourier, CNRS-IN2P3, Institut Polytechnique de Grenoble, Grenoble, France
K. Redlich National Centre for Nuclear Studies, Warsaw, Poland
R. J. Reed Yale University, New Haven, Connecticut United States
A. Rehman Department of Physics and Technology, University of Bergen, Bergen, Norway
P. Reichelt Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
M. Reicher Nikhef, National Institute for Subatomic Physics and Institute for Subatomic Physics of Utrecht University, Utrecht, Netherlands
R. Renfordt Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
A. R. Reolon Laboratori Nazionali di Frascati, INFN, Frascati, Italy
A. Reshetin Institute for Nuclear Research, Academy of Sciences, Moscow, Russia
F. Rettig Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
J.-P. Revol European Organization for Nuclear Research (CERN), Geneva, Switzerland
K. Reygers Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
L. Riccati Sezione INFN, Turin, Italy
R. A. Ricci Laboratori Nazionali di Legnaro, INFN, Legnaro, Italy
T. Richert Division of Experimental High Energy Physics, University of Lund, Lund, Sweden
M. Richter Department of Physics, University of Oslo, Oslo, Norway
P. Riedler European Organization for Nuclear Research (CERN), Geneva, Switzerland
W. Riegler European Organization for Nuclear Research (CERN), Geneva, Switzerland
F. Riggi Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Catania, Italy Sezione INFN, Catania, Italy
A. Rivetti Sezione INFN, Turin, Italy
M. Rodríguez Cahuantzi Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
A. Rodriguez Manso Nikhef, National Institute for Subatomic Physics, Amsterdam, Netherlands
K. Røed Department of Physics and Technology, University of Bergen, Bergen, Norway Department of Physics, University of Oslo, Oslo, Norway
E. Rogochaya Joint Institute for Nuclear Research (JINR), Dubna, Russia
D. Rohr Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
D. Röhrich Department of Physics and Technology, University of Bergen, Bergen, Norway
R. Romita Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany Nuclear Physics Group, STFC Daresbury Laboratory, Daresbury, United Kingdom
F. Ronchetti Laboratori Nazionali di Frascati, INFN, Frascati, Italy
P. Rosnet Laboratoire de Physique Corpusculaire (LPC), Clermont Université, Université Blaise Pascal, CNRS–IN2P3, Clermont-Ferrand, France
S. Rossegger European Organization for Nuclear Research (CERN), Geneva, Switzerland
A. Rossi European Organization for Nuclear Research (CERN), Geneva, Switzerland
P. Roy Saha Institute of Nuclear Physics, Kolkata, India
C. Roy Institut Pluridisciplinaire Hubert Curien (IPHC), Université de Strasbourg, CNRS-IN2P3, Strasbourg, France
A. J. Rubio Montero Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
R. Rui Dipartimento di Fisica dell’Università and Sezione INFN, Trieste, Italy
R. Russo Dipartimento di Fisica dell’Università and Sezione INFN, Turin, Italy
E. Ryabinkin Russian Research Centre Kurchatov Institute, Moscow, Russia
A. Rybicki The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
S. Sadovsky Institute for High Energy Physics, Protvino, Russia
K. Šafařík European Organization for Nuclear Research (CERN), Geneva, Switzerland
R. Sahoo Indian Institute of Technology Indore (IITI), Indore, India
P. K. Sahu Institute of Physics, Bhubaneswar, India
J. Saini Variable Energy Cyclotron Centre, Kolkata, India
H. Sakaguchi Hiroshima University, Hiroshima, Japan
S. Sakai Lawrence Berkeley National Laboratory, Berkeley, California United States
D. Sakata University of Tsukuba, Tsukuba, Japan
C. A. Salgado Departamento de Física de Partículas and IGFAE, Universidad de Santiago de Compostela, Santiago de Compostela, Spain
J. Salzwedel Department of Physics, Ohio State University, Columbus, Ohio United States
S. Sambyal Physics Department, University of Jammu, Jammu, India
V. Samsonov Petersburg Nuclear Physics Institute, Gatchina, Russia
X. Sanchez Castro Institut Pluridisciplinaire Hubert Curien (IPHC), Université de Strasbourg, CNRS-IN2P3, Strasbourg, France
L. Šándor Institute of Experimental Physics, Slovak Academy of Sciences, Košice, Slovakia
A. Sandoval Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
M. Sano University of Tsukuba, Tsukuba, Japan
G. Santagati Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Catania, Italy
R. Santoro Centro Fermi - Museo Storico della Fisica e Centro Studi e Ricerche “Enrico Fermi”, Rome, Italy European Organization for Nuclear Research (CERN), Geneva, Switzerland
J. Sarkamo Helsinki Institute of Physics (HIP) and University of Jyväskylä, Jyväskylä, Finland
D. Sarkar Variable Energy Cyclotron Centre, Kolkata, India
E. Scapparone Sezione INFN, Bologna, Italy
F. Scarlassara Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Padova, Italy
R. P. Scharenberg Purdue University, West Lafayette, Indiana United States
C. Schiaua National Institute for Physics and Nuclear Engineering, Bucharest, Romania
R. Schicker Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
H. R. Schmidt Eberhard Karls Universität Tübingen, Tübingen, Germany
C. Schmidt Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
S. Schuchmann Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
J. Schukraft European Organization for Nuclear Research (CERN), Geneva, Switzerland
T. Schuster Yale University, New Haven, Connecticut United States
Y. Schutz European Organization for Nuclear Research (CERN), Geneva, Switzerland SUBATECH, Ecole des Mines de Nantes, Université de Nantes, CNRS-IN2P3, Nantes, France
K. Schwarz Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
K. Schweda Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
G. Scioli Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Bologna, Italy
E. Scomparin Sezione INFN, Turin, Italy
R. Scott University of Tennessee, Knoxville, Tennessee United States
P. A. Scott School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
G. Segato Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Padova, Italy
I. Selyuzhenkov Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
S. Senyukov Institut Pluridisciplinaire Hubert Curien (IPHC), Université de Strasbourg, CNRS-IN2P3, Strasbourg, France
J. Seo Pusan National University, Pusan, South Korea
S. Serci Dipartimento di Fisica dell’Università and Sezione INFN, Cagliari, Italy
E. Serradilla Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
A. Sevcenco Institute of Space Sciences (ISS), Bucharest, Romania
A. Shabetai SUBATECH, Ecole des Mines de Nantes, Université de Nantes, CNRS-IN2P3, Nantes, France
G. Shabratova Joint Institute for Nuclear Research (JINR), Dubna, Russia
R. Shahoyan European Organization for Nuclear Research (CERN), Geneva, Switzerland
S. Sharma Physics Department, University of Jammu, Jammu, India
N. Sharma University of Tennessee, Knoxville, Tennessee United States
S. Rohni Physics Department, University of Jammu, Jammu, India
K. Shigaki Hiroshima University, Hiroshima, Japan
K. Shtejer Centro de Aplicaciones Tecnológicas y Desarrollo Nuclear (CEADEN), Havana, Cuba
Y. Sibiriak Russian Research Centre Kurchatov Institute, Moscow, Russia
E. Sicking Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, Münster, Germany
S. Siddhanta Sezione INFN, Cagliari, Italy
T. Siemiarczuk National Centre for Nuclear Studies, Warsaw, Poland
D. Silvermyr Oak Ridge National Laboratory, Oak Ridge, Tennessee United States
C. Silvestre Laboratoire de Physique Subatomique et de Cosmologie (LPSC), Université Joseph Fourier, CNRS-IN2P3, Institut Polytechnique de Grenoble, Grenoble, France
G. Simatovic Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City, Mexico Rudjer Bošković Institute, Zagreb, Croatia
G. Simonetti European Organization for Nuclear Research (CERN), Geneva, Switzerland
R. Singaraju Variable Energy Cyclotron Centre, Kolkata, India
R. Singh Physics Department, University of Jammu, Jammu, India
S. Singha National Institute of Science Education and Research, Bhubaneswar, India Variable Energy Cyclotron Centre, Kolkata, India
V. Singhal Variable Energy Cyclotron Centre, Kolkata, India
T. Sinha Saha Institute of Nuclear Physics, Kolkata, India
B. C. Sinha Variable Energy Cyclotron Centre, Kolkata, India
B. Sitar Faculty of Mathematics, Physics and Informatics, Comenius University, Bratislava, Slovakia
M. Sitta Dipartimento di Scienze e Innovazione Tecnologica dell’Università del Piemonte Orientale and Gruppo Collegato INFN, Alessandria, Italy
T. B. Skaali Department of Physics, University of Oslo, Oslo, Norway
K. Skjerdal Department of Physics and Technology, University of Bergen, Bergen, Norway
R. Smakal Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
N. Smirnov Yale University, New Haven, Connecticut United States
R. J. M. Snellings Nikhef, National Institute for Subatomic Physics and Institute for Subatomic Physics of Utrecht University, Utrecht, Netherlands
C. Søgaard Division of Experimental High Energy Physics, University of Lund, Lund, Sweden
R. Soltz Lawrence Livermore National Laboratory, Livermore, California United States
M. Song Yonsei University, Seoul, South Korea
J. Song Pusan National University, Pusan, South Korea
C. Soos European Organization for Nuclear Research (CERN), Geneva, Switzerland
F. Soramel Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Padova, Italy
I. Sputowska The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
M. Spyropoulou-Stassinaki Physics Department, University of Athens, Athens, Greece
B. K. Srivastava Purdue University, West Lafayette, Indiana United States
J. Stachel Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
I. Stan Institute of Space Sciences (ISS), Bucharest, Romania
G. Stefanek National Centre for Nuclear Studies, Warsaw, Poland
M. Steinpreis Department of Physics, Ohio State University, Columbus, Ohio United States
E. Stenlund Division of Experimental High Energy Physics, University of Lund, Lund, Sweden
G. Steyn Physics Department, University of Cape Town and iThemba LABS, National Research Foundation, Somerset West, South Africa
J. H. Stiller Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
D. Stocco SUBATECH, Ecole des Mines de Nantes, Université de Nantes, CNRS-IN2P3, Nantes, France
M. Stolpovskiy Institute for High Energy Physics, Protvino, Russia
P. Strmen Faculty of Mathematics, Physics and Informatics, Comenius University, Bratislava, Slovakia
A. A. P. Suaide Universidade de São Paulo (USP), São Paulo, Brazil
M. A. Subieta Vásquez Dipartimento di Fisica dell’Università and Sezione INFN, Turin, Italy
T. Sugitate Hiroshima University, Hiroshima, Japan
C. Suire Institut de Physique Nucléaire d’Orsay (IPNO), Université Paris-Sud, CNRS-IN2P3, Orsay, France
M. Suleymanov COMSATS Institute of Information Technology (CIIT), Islamabad, Pakistan
R. Sultanov Institute for Theoretical and Experimental Physics, Moscow, Russia
M. Šumbera Nuclear Physics Institute, Academy of Sciences of the Czech Republic, Řež u Prahy, Czech Republic
T. Susa Rudjer Bošković Institute, Zagreb, Croatia
T. J. M. Symons Lawrence Berkeley National Laboratory, Berkeley, California United States
A. Szanto de Toledo Universidade de São Paulo (USP), São Paulo, Brazil
I. Szarka Faculty of Mathematics, Physics and Informatics, Comenius University, Bratislava, Slovakia
A. Szczepankiewicz European Organization for Nuclear Research (CERN), Geneva, Switzerland
M. Szymański Warsaw University of Technology, Warsaw, Poland
J. Takahashi Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil
M. A. Tangaro Dipartimento Interateneo di Fisica ‘M. Merlin’ and Sezione INFN, Bari, Italy
J. D. Tapia Takaki Institut de Physique Nucléaire d’Orsay (IPNO), Université Paris-Sud, CNRS-IN2P3, Orsay, France
A. Tarantola Peloni Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
A. Tarazona Martinez European Organization for Nuclear Research (CERN), Geneva, Switzerland
A. Tauro European Organization for Nuclear Research (CERN), Geneva, Switzerland
G. Tejeda Muñoz Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
A. Telesca European Organization for Nuclear Research (CERN), Geneva, Switzerland
A. Ter Minasyan Russian Research Centre Kurchatov Institute, Moscow, Russia
C. Terrevoli Dipartimento Interateneo di Fisica ‘M. Merlin’ and Sezione INFN, Bari, Italy
J. Thäder Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
D. Thomas Nikhef, National Institute for Subatomic Physics and Institute for Subatomic Physics of Utrecht University, Utrecht, Netherlands
R. Tieulent Université de Lyon, Université Lyon 1, CNRS/IN2P3, IPN-Lyon, Villeurbanne, France
A. R. Timmins University of Houston, Houston, Texas United States
D. Tlusty Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
A. Toia Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Padova, Italy Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany Sezione INFN, Padova, Italy
H. Torii University of Tokyo, Tokyo, Japan
L. Toscano Sezione INFN, Turin, Italy
V. Trubnikov Bogolyubov Institute for Theoretical Physics, Kiev, Ukraine
D. Truesdale Department of Physics, Ohio State University, Columbus, Ohio United States
W. H. Trzaska Helsinki Institute of Physics (HIP) and University of Jyväskylä, Jyväskylä, Finland
T. Tsuji University of Tokyo, Tokyo, Japan
A. Tumkin Russian Federal Nuclear Center (VNIIEF), Sarov, Russia
R. Turrisi Sezione INFN, Padova, Italy
T. S. Tveter Department of Physics, University of Oslo, Oslo, Norway
J. Ulery Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
K. Ullaland Department of Physics and Technology, University of Bergen, Bergen, Norway
J. Ulrich Institut für Informatik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany Kirchhoff-Institut für Physik, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
A. Uras Université de Lyon, Université Lyon 1, CNRS/IN2P3, IPN-Lyon, Villeurbanne, France
G. M. Urciuoli Sezione INFN, Rome, Italy
G. L. Usai Dipartimento di Fisica dell’Università and Sezione INFN, Cagliari, Italy
M. Vajzer Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic Nuclear Physics Institute, Academy of Sciences of the Czech Republic, Řež u Prahy, Czech Republic
M. Vala Institute of Experimental Physics, Slovak Academy of Sciences, Košice, Slovakia Joint Institute for Nuclear Research (JINR), Dubna, Russia
L. Valencia Palomo Institut de Physique Nucléaire d’Orsay (IPNO), Université Paris-Sud, CNRS-IN2P3, Orsay, France
S. Vallero Dipartimento di Fisica dell’Università and Sezione INFN, Turin, Italy
P. Vande Vyvre European Organization for Nuclear Research (CERN), Geneva, Switzerland
J. W. Van Hoorne European Organization for Nuclear Research (CERN), Geneva, Switzerland
M. van Leeuwen Nikhef, National Institute for Subatomic Physics and Institute for Subatomic Physics of Utrecht University, Utrecht, Netherlands
L. Vannucci Laboratori Nazionali di Legnaro, INFN, Legnaro, Italy
A. Vargas Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
R. Varma Indian Institute of Technology Bombay (IIT), Mumbai, India
M. Vasileiou Physics Department, University of Athens, Athens, Greece
A. Vasiliev Russian Research Centre Kurchatov Institute, Moscow, Russia
V. Vechernin V. Fock Institute for Physics, St. Petersburg State University, St. Petersburg, Russia
M. Veldhoen Nikhef, National Institute for Subatomic Physics and Institute for Subatomic Physics of Utrecht University, Utrecht, Netherlands
M. Venaruzzo Dipartimento di Fisica dell’Università and Sezione INFN, Trieste, Italy
E. Vercellin Dipartimento di Fisica dell’Università and Sezione INFN, Turin, Italy
S. Vergara Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
R. Vernet Centre de Calcul de l’IN2P3, Villeurbanne, France
M. Verweij Nikhef, National Institute for Subatomic Physics and Institute for Subatomic Physics of Utrecht University, Utrecht, Netherlands
L. Vickovic Technical University of Split FESB, Split, Croatia
G. Viesti Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Padova, Italy
J. Viinikainen Helsinki Institute of Physics (HIP) and University of Jyväskylä, Jyväskylä, Finland
Z. Vilakazi Physics Department, University of Cape Town and iThemba LABS, National Research Foundation, Somerset West, South Africa
O. Villalobos Baillie School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
Y. Vinogradov Russian Federal Nuclear Center (VNIIEF), Sarov, Russia
L. Vinogradov V. Fock Institute for Physics, St. Petersburg State University, St. Petersburg, Russia
A. Vinogradov Russian Research Centre Kurchatov Institute, Moscow, Russia
T. Virgili Dipartimento di Fisica ‘E.R. Caianiello’ dell’Università and Gruppo Collegato INFN, Salerno, Italy
Y. P. Viyogi Variable Energy Cyclotron Centre, Kolkata, India
A. Vodopyanov Joint Institute for Nuclear Research (JINR), Dubna, Russia
M. A. Völkl Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
S. Voloshin Wayne State University, Detroit, Michigan United States
K. Voloshin Institute for Theoretical and Experimental Physics, Moscow, Russia
G. Volpe European Organization for Nuclear Research (CERN), Geneva, Switzerland
B. von Haller European Organization for Nuclear Research (CERN), Geneva, Switzerland
I. Vorobyev V. Fock Institute for Physics, St. Petersburg State University, St. Petersburg, Russia
D. Vranic European Organization for Nuclear Research (CERN), Geneva, Switzerland Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
J. Vrláková Faculty of Science, P.J. Šafárik University, Košice, Slovakia
B. Vulpescu Laboratoire de Physique Corpusculaire (LPC), Clermont Université, Université Blaise Pascal, CNRS–IN2P3, Clermont-Ferrand, France
A. Vyushin Russian Federal Nuclear Center (VNIIEF), Sarov, Russia
V. Wagner Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
B. Wagner Department of Physics and Technology, University of Bergen, Bergen, Norway
R. Wan Central China Normal University, Wuhan, China
Y. Wang Central China Normal University, Wuhan, China
Y. Wang Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
M. Wang Central China Normal University, Wuhan, China
K. Watanabe University of Tsukuba, Tsukuba, Japan
M. Weber University of Houston, Houston, Texas United States
J. P. Wessels European Organization for Nuclear Research (CERN), Geneva, Switzerland Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, Münster, Germany
U. Westerhoff Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, Münster, Germany
J. Wiechula Eberhard Karls Universität Tübingen, Tübingen, Germany
J. Wikne Department of Physics, University of Oslo, Oslo, Norway
M. Wilde Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, Münster, Germany
G. Wilk National Centre for Nuclear Studies, Warsaw, Poland
M. C. S. Williams Sezione INFN, Bologna, Italy
B. Windelband Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
C. G. Yaldo Wayne State University, Detroit, Michigan United States
Y. Yamaguchi University of Tokyo, Tokyo, Japan
S. Yang Department of Physics and Technology, University of Bergen, Bergen, Norway
P. Yang Central China Normal University, Wuhan, China
H. Yang Commissariat à l’Energie Atomique, IRFU, Saclay, France Nikhef, National Institute for Subatomic Physics and Institute for Subatomic Physics of Utrecht University, Utrecht, Netherlands
S. Yasnopolskiy Russian Research Centre Kurchatov Institute, Moscow, Russia
J. Yi Pusan National University, Pusan, South Korea
Z. Yin Central China Normal University, Wuhan, China
I.-K. Yoo Pusan National University, Pusan, South Korea
J. Yoon Yonsei University, Seoul, South Korea
X. Yuan Central China Normal University, Wuhan, China
I. Yushmanov Russian Research Centre Kurchatov Institute, Moscow, Russia
V. Zaccolo Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
C. Zach Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
C. Zampolli Sezione INFN, Bologna, Italy
S. Zaporozhets Joint Institute for Nuclear Research (JINR), Dubna, Russia
A. Zarochentsev V. Fock Institute for Physics, St. Petersburg State University, St. Petersburg, Russia
P. Závada Institute of Physics, Academy of Sciences of the Czech Republic, Prague, Czech Republic
N. Zaviyalov Russian Federal Nuclear Center (VNIIEF), Sarov, Russia
H. Zbroszczyk Warsaw University of Technology, Warsaw, Poland
P. Zelnicek Institut für Informatik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
I. S. Zgura Institute of Space Sciences (ISS), Bucharest, Romania
M. Zhalov Petersburg Nuclear Physics Institute, Gatchina, Russia
Y. Zhang Central China Normal University, Wuhan, China
H. Zhang Central China Normal University, Wuhan, China
X. Zhang Central China Normal University, Wuhan, China Laboratoire de Physique Corpusculaire (LPC), Clermont Université, Université Blaise Pascal, CNRS–IN2P3, Clermont-Ferrand, France Lawrence Berkeley National Laboratory, Berkeley, California United States
D. Zhou Central China Normal University, Wuhan, China
Y. Zhou Nikhef, National Institute for Subatomic Physics and Institute for Subatomic Physics of Utrecht University, Utrecht, Netherlands
F. Zhou Central China Normal University, Wuhan, China
H. Zhu Central China Normal University, Wuhan, China
J. Zhu Central China Normal University, Wuhan, China
X. Zhu Central China Normal University, Wuhan, China
J. Zhu Central China Normal University, Wuhan, China
A. Zichichi Centro Fermi - Museo Storico della Fisica e Centro Studi e Ricerche “Enrico Fermi”, Rome, Italy Dipartimento di Fisica e Astronomia dell’Università and Sezione INFN, Bologna, Italy
A. Zimmermann Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
G. Zinovjev Bogolyubov Institute for Theoretical Physics, Kiev, Ukraine
Y. Zoccarato Université de Lyon, Université Lyon 1, CNRS/IN2P3, IPN-Lyon, Villeurbanne, France
M. Zynovyev Bogolyubov Institute for Theoretical Physics, Kiev, Ukraine
M. Zyzak Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany

Collapse

D meson elliptic flow in noncentral Pb-Pb collisions at sqrt[sNN]=2.76 Tev

Azimuthally anisotropic distributions of D0, D+, and D*+ mesons were studied in the central rapidity region (|y|<0.8) in Pb-Pb collisions at a center-of-mass energy sqrt[sNN]=2.76  TeV per nucleon-nucleon collision, with the ALICE detector at the LHC. The second Fourier coefficient v2 (commonly denoted elliptic flow) was measured in the centrality class 30%-50% as a function of the D meson transverse momentum pT, in the range 2-16  GeV/c. The measured v2 of D mesons is comparable in magnitude to that of light-flavor hadrons. It is positive in the range 2<pT<6  GeV/c with 5.7σ significance, based on the combination of statistical and systematic uncertainties.